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Summary 
Mitosis is the process by which sister chromatids are equally segregated into two 
daughter cells. Tight control in various events during mitotic progression is essential for 
maintaining chromosome stability. Mitotic kinases including Cyclin dependent kinase 1 
(Cdk1) and Aurora family are required for regulating proper mitotic progression by 
phosphorylating mitotic substrates thereby, controlling their activities, localization or 
abundance. On the other hand, these mitotic kinases are modulated by de-novo 
synthesis, activators, phosphorylation and ubiquitin-dependent proteolysis. A thorough 
understanding of the function and regulation of mitotic kinases could further our 
knowledge on mitotic progression. 
In the first part of the thesis, we investigated the expression, localization and 
regulation of human Lats1 kinase, which is a close homologue of the yeast Dbf2 kinase 
family involved in the mitotic exit network (MEN). Despite the fact that Lats1 has been 
suggested to be a spindle protein that binds and inactivates Cdk1, we found that Lats1 
is mainly cytoplasmic throughout the cell cycle by immunofluorescence microscopy. 
Both yeast two-hybrid and coimmunoprecipitation showed no significant interaction 
between Lats1 and Cdk1. Although Lats1 was highly phosphorylated during mitosis, no 
detectable kinase activity was observed. However, we identified Ste20 like kinase MST2 
as the upstream regulator of human Lats1. Phosphorylation of Lats1 by Mst2 resulted in 
the activation of Lats1 kinase activity both in vivo and in vitro. This kinase-substrate 
relation was proven to be specific, as another distant Mst2 homolog, Mst4, did not 
possess this ability. Subsequent mass-spectrometry-based phosphosites analysis 
revealed that Mst2 phosphorylates Lats1 on more than five residues. Alanine mutations 
on Lats1T1079 and S909 impaired Lats1 kinase activity. Thus, we could not confirm the 
suggested role of Lat1 in mitosis. Instead, we show that similar to its Drosophila 
ortholog, Lats1 is involved in the Mst2 signaling pathway and might control 
developmentally regulated cell proliferation and apoptosis in mammals.  
In the second part of this thesis, we characterized hBora, a novel Aurora A 
interactor originally found in Drosophila. We show that hBora is upregulated and 
phosphorylated during mitosis. siRNA-mediated knockdown of hBora led to spindle 
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formation defects and aneuploidy. hBora overexpression caused monoastral spindle 
formation and mislocalization not only of Aurora A but also Plk1. Further investigations 
showed that Cdk1 phosphorylation on hBoraSer252 leads to Plk1 binding and this may 
promote the SCF-mediated proteolysis of hBora. Indeed, Plk1 depletion led to an 
increase in hBora levels. Interestingly, the co-depletion of both hBora and Plk1 (to lower 
hBora levels in Plk1 depleted cells) rescued the localization of Aurora A to the 
centrosomes and bipolar spindle formation. Thus, we propose that hBora is a functional 
link between Plk1 and Aurora A and that by modulating the proteolysis of hBora, Plk1 
could regulate Aurora A localization and activity. At the end, we also investigated the 
function of Aurora A and could show that Aurora A is required for centriole cohesion and 
centrosome separation.  
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Introduction 
An overview of the cell cycle 
The cell cycle is an ordered set of events that leads to the reproduction of two 
identical cells. The events culminating in cell duplication and division are in order: G1 
(Gap phase1), S (Synthesis phase), G2 (Gap phase2) and M (Mitosis and cytokinesis) 
phase (Fig. 1). G1, S and G2 phases are collectively known as interphase, in which the 
cell spends most of its time. DNA replication occurs in S phase and the two gap phases, 
G1 (between M phase and S phase) and G2 (between S phase and M phase) allow the 
cell to grow and to prepare for the next phase. The M phase comprises the segregation 
of duplicated chromosomes (mitosis) and the distribution of chromosomes into two 
daughter cells (cytokinesis). 
 
 
An overview of mitosis 
Although being relatively brief, mitosis is the most dramatic event during the cell cycle. 
Mitosis is divided into 5 stages: prophase, prometaphase, metaphase, anaphase and 
telophase (Fig. 2). At prophase, the chromosomes undergo condensation. The two 
centrosomes, the major microtubule-organizing centres (MTOC) in animal cells 
(duplicated previously in S phase), increase the nucleation of highly dynamic 
microtubules (MTs). This leads to the separation of centrosomes and spindle aster 
formation (Doxsey, 1998; Luders and Stearns, 2007; Meraldi and Nigg, 2002). During 
Figure 1. The cell cycle.  
Cell cycle begins with duplication of the 
cell´s components, including exact 
duplication of each chromosome in S 
phase. These components are then 
divided equally between two daughter 
cells in M phase. Image adapted from 
“The Science Creative Quarterly”, URL 
(scq.ubc.ca), artist: Jane Wang. 
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prometaphase, the nuclear envelope is broken down. MTs are captured by kinetochores 
situated on the centromeres of the mitotic chromosomes (Rieder, 2005). The capture of 
MTs emanating from opposite poles by sister chromatids promotes the congression of 
chromosomes, which then align at the equator of the spindle to form the metaphase 
plate. Once each sister-chromatid pair is attached to the opposite poles to form a 
bipolar mitotic spindle, the spindle checkpoint is inactivated which then leads to 
anaphase onset. At anaphase, the paired chromatids synchronously separate due to 
sudden loss in sister chromatid cohesion and each chromatid is then pulled towards the 
poles by shortening of kinetochore MTs (Anaphase A). The centrosomes move towards 
the cell cortex assisting further sister chromatid separation. (Anaphase B). During 
telophase, the chromosomes arrive at the poles of the spindle, the nuclear envelope 
reforms around the daughter chromosomes, and chromatin decondensation begins. 
Cytokinesis, the division of the cytoplasm, starts with the contraction of an actomyosin-
based contractile ring, which assembles at the site of the spindle midzone and pinches 
into the cell to create two daughters, each with one nucleus and one centrosome (Pines 
and Rieder, 2001) 
 
Figure 2. M phase progression in animal somatic cells. 
Schematic representation of different stages of mitosis and cytokinesis. Mitosis is broadly divided into 
prophase, prometaphase, metaphase, anaphase and telophase. Cytokinesis is closely linked to mitosis. 
The colours shown here are brown for DNA, light green for centrosomes and dark green for MTs. Image 
adapted from Alberts et al., Molecular Biology of the Cell, fourth edition, 2002. 
                                                                                                                                                    Introduction                           
5 
Regulation of mitotic progression by kinases 
Rigorous control of mitotic events is essential for the successful completion of 
cell division and it is mediated by two major regulatory mechanisms: phosphorylation 
and proteolysis. These two mechanisms are interdependent as the proteolytic 
machinery is controlled by phosphorylation and many mitotic kinases are downregulated 
by degradation. Figure 3 summarizes the role of different mitotic kinases at different 
stages of mitosis. 
 
 
Cyclin-dependent kinase 1 
Intense studies from the past decades had brought to light a number of kinases 
involved in the control of mitosis including the Polo and Aurora family kinases. 
Nevertheless, Cyclin-dependent kinase 1 (Cdk1), which is a founding member of a 
family of heterodimeric serine/threonine protein kinases termed Cdks (Cyclin-dependent 
kinases) (Morgan, 1997; Murray, 2004; Nigg, 2001) remains the most prominent mitotic 
kinase. Similar to other Cdks, Cdk1 consists of a catalytic subunit that has to bind to a 
regulatory subunit (called cyclin) in order to become enzymatically active (Hunt, 1991; 
Nigg, 1995). The protein levels of cyclins fluctuate during the cell cycle in a controlled 
manner (Evans et al., 1983) and this then directly regulates Cdk’s activities. In 
Figure 3. Role of mitotic 
kinases at different stages 
of mitosis. Image adapted 
from Nigg, Nature Reviews, 
Molecular Cell Biology, Vol.
2, January, 2001. 
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mammals, the activation of Cdk1 at the G2/M transition depends on the binding of cyclin 
A/B and dephosphorylation of two neighbouring residues in the ATP-binding site 
(threonine 14 and tyrosine 15) by Cdc25C which antagonizes the actions of Wee1 and 
Myt1 kinases (Ohi and Gould, 1999). Moreover, complete activation of the Cdk1 kinase 
is accomplished by phosphorylation of threonine 161 on the activation loop of Cdk1 
(Makela et al., 1994; Nigg, 1996) by the Cdk-activating kinase (CAK) (Harper and 
Adams, 2001). Active Cdk1 first appears predominantly on centrosomes in prophase 
cells (Jackman et al., 2003). Its phosphorylation of numerous substrates, including 
nuclear lamins, condensins and microtubule-binding proteins, is essential for nuclear 
envelope breakdown, chromosome condensation, and spindle assembly, respectively 
(Andersen, 1999; Nigg, 1995). Furthermore, Cdk1-cyclin A/B complexes regulate the 
anaphase-promoting complex/cyclosome (APC/C), the major ubiquitin-dependent 
proteolytic machinery, which controls the timely degradation of critical mitotic regulators 
such as cyclin B (Peters, 2006). Thus, upon cyclin B destruction, Cdk1 becomes 
inactive, and Cdk1 substrates are dephosphorylated by counteracting phosphatases, 
which promotes mitotic exit and cytokinesis by facilitating nuclear envelope reformation, 
spindle disassembly and chromosome decondensation. 
Polo-like kinase 1 (Plk1) 
Polo-like kinases (Plks) have drawn much attention recently because of their 
close collaboration with Cdk1 in regulating mitotic events and the uncovering of Plk 
regulatory mechanisms. Polo-like kinase 1 (Plk1) is the most well-characterized Plk 
among the 4 family members in mammals and is highly conserved from yeast to human 
(Barr et al., 2004). The localization of Plk1 undergoes a highly dynamic change 
throughout mitosis, from the centrosomes, spindle poles and kinetochores to the central 
spindle and postmitotic bridge (Fig. 4).  
Figure 4. Localization of 
Plk1 (in red, arrows) during 
mitosis. Images adapted 
from Barr et al., Nature 
Reviews on Molecular Cell 
Biology, 2004.  
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Structurally, Plk1 features a C-terminal polo-box domain (PBD), which functions 
as a phosphopeptide-binding motif (Fig. 4) (Elia et al., 2003a). The PBD has been 
shown to be required for Plk1’s targeting to substrates and subcellular localization (Lee 
et al., 1999; Reynolds and Ohkura, 2003; Seong et al., 2002). The PBD binds to 
phoshopeptides containing the consensus sequence S-pS/pT-P/X and the two residues 
His538 and Lys540 of PB2 are responsible for the binding (Cheng et al., 2003; Elia et 
al., 2003a; Elia et al., 2003b). Interestingly, the PBD can also interact with the kinase 
domain of Plk1, resulting in an inhibition of function, at least in vitro (Jang et al., 2002). 
This thus led to the hypothesis that upon prior phosphorylation by proline-directed 
serine/threonine kinase, the so-called priming kinases, phosphoproteins dock to the 
PBD. This liberates the catalytic domain of Plk1 due to a conformational change and 
thus promotes Plk1 kinase activation. Active Plk1 could then phosphorylate either the 
docking protein itself or other downstream targets (Fig. 5). Current evidence shows that 
Cdk1/Cyclin B is the most prominent priming kinase that phosphorylates Plk1 docking 
proteins. Nevertheless, MAP kinase Erk2 (Fabbro et al., 2005), Calmodulin dependent 
kinase II (CaMKII) (Rauh et al., 2005) and Plk1 itself (Neef et al., 2003) have also been 
shown as priming kinases. 
  




Figure 5. Plk1 domain structure and its regulation model.  
A) Plk1 N-terminal habours the catalytic domain whereas the C-terminal PBD is required for targeting. 
Residues essential for activation, destruction and phosphopeptide binding are indicated. B) Model of Plk1 
targeting to a docking protein prephosphorylated by a priming kinase, which then induces Plk1 kinase 
activity. Illustrations adapted from Barr et al., Nature Reviews on Molecular Cell Biology, 2004. 
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 Plk1 has been implicated in regulating various stages of mitosis. Evidence 
suggests that together with Cdk1/Cyclin B, Plk1 is part of the amplification loop to 
trigger mitotic entry by regulating Cdc25C or Wee1 (van Vugt and Medema, 2005). In 
accordance with its localization to the centrosome and spindle poles, Plk1 is involved in 
centrosome maturation and separation at early mitosis (Barr et al., 2004; Glover, 2005). 
For instance, the phosphorylation of ninein-like protein (Nlp) and Kizuna by Plk1 has 
been shown to be required for the centrosomal MT nucleation process and the 
maintenance of spindle pole integrity, respectively (Casenghi et al., 2003; Oshimori et 
al., 2006). In addition, the centrosomal localization of another mitotic kinase, Aurora A, 
has also been shown to be dependent on Plk1 (De Luca et al., 2006; Hanisch et al., 
2006).  At metaphase-anaphase transition, Plk1 promotes the dissociation of 
chromosome cohesion by regulating cohesin, which holds the two sister chromatids 
together and shugoshin, which acts as a guardian for cohesion (Uhlmann, 2004; 
Watanabe, 2005). As mentioned previously, APC/C is essential for the timely 
degradation of numerous mitotic players for mitotic exit (Peters, 2006). At 
prometaphase, Emi1 is targeted for SCFβ-TrCP mediated degradation after Plk1 
phosphorylating its degron motif, which thus activates APC/C (Moshe et al., 2004; 
Schmidt et al., 2006). Together with Cdk1, Plk1 has also been shown to directly 
phosphorylate and activate different APC/C subunits at anaphase onset (Barr et al., 
2004; Kraft et al., 2003) and further investigation is required to elucidate the role of Plk1 
in this activation process. Finally, Plk1 modulates cytokinesis by phosphorylating other 
targets such as MKlp2 and Ect2 (Neef et al., 2003; Niiya et al., 2006).  
Aurora kinase family 
Aurora kinases were first identified in Drosophila, in a screen for mutated genes 
that leads to mitotic spindle and centrosome abnormalities (Glover et al., 1995). There 
are three Aurora kinases in mammals (Meraldi et al., 2004). Aurora A was found to be 
associated predominantly with the centrosomes and spindle from prophase to telophase 
(Berdnik and Knoblich, 2002). Aurora A localization and kinase activity is controlled by 
TPX2, a microtubules binding protein involved in the Ran-GTP mediated spindle 
assembly pathway. TPX2 targets Aurora A to the spindle and, moreover, TPX2 binding 
                                                                                                                                                    Introduction                           
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keeps the phosphorylated activation segment (containing T288) of Aurora A in a 
conformationally active state, thus protecting Aurora A from inactivation by protein 
phosphatase 1 (PP1) (Fig. 6) (Bayliss et al., 2003; Kufer et al., 2003). Two other 
proteins, Ajuba and Bora have also been implicated in Aurora A kinase activation 
(Hirota et al., 2003; Hutterer et al., 2006), but their precise roles in Aurora A regulation 
require further study. 
  
Figure 6. Schematic representation of the molecular mechanism of TPX2-mediated activation of 
Aurora A. The upstream stretch of TPX2 (red) anchors the TPX2 to the N-terminal lobe of Aurora A. The 
downstream stretch (pink helix) hooks the activation segment triggering a lever-arm-like movement, 
where rotations at His280AUR and Pro282AUR pull on Thr288AUR, thus preventing the action of PP1. Figure 
adapted from Bayliss et al., Molecular Cell, 2003. 
 
Aurora A activity is closely correlated with mitotic entry, the maturation of mitotic 
centrosomes and spindle assembly. Moreover, Aurora A controls the timely mitotic entry 
by modulating nuclear envelope breakdown (Hachet et al., 2007; Portier et al., 2007). It 
assists in the centrosome maturation by recruiting proteins such as γ-tubulin (Berdnik 
and Knoblich, 2002), D-TACC (Drosophila-Transforming, Acidic, Coiled Coil containing 
protein) (Giet et al., 2002), SPD-2 (Kemp et al., 2004), centrosomin (Terada et al., 
2003) and chTOG (colonic and hepatic tumour overexpressed protein) (Conte et al., 
2003) and, consequently, participates in spindle assembly and stability. Nevertheless, 
the molecular mechanisms of Aurora A function still remain obscure. A number of 
proteins have been identified to be Aurora A binding partners or substrates, but it is 
unclear whether all of these protein substrates actually are phosphorylated by Aurora A 
in vivo  (Table 1) (Li and Li, 2006). 
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Protein Characteristic Function 
Ajuba Cell-cell adhesion protein Activates Aurora A in G2 
BRCA1 Breast cancer susceptibilty gene 
BRCA1 phosphorylation by Aurora A plays a role 
in G2/M transtiton 
CDC25B 
Phosphotase activating 
Cdk1/CyclinB Key activator of cell cycle 





Controls polyadenylation induced translation in 
germ cells 
Eg5 Mitotic kinesin Centrosome seperation and spindle bipolarity 
Lats2 Tumor suppressor gene Cell cyle regulation 
p53 
Transcritpion factor, tumor 
suppressor 
Centrosomal p53 when phosphorylated 




Recruits Xklp2 kinesin to microtubules, activates 
Aurora A targeting the mitotic spindle 
TACC1, 2, 3 
Transforming acidic 
coiled coil 
Regulates microtubule dynamics ,localizes D-
TACC and its binding 
PP1 Protein phosphatase 1 
Regulator of cellular functions such as division, 
homeostasis and apoptosis 
Bora Cytoplasmic and nuclear protein Activates Aurora A in G2 
Histone H3 DNA-associated protein 
Together with other histones associates with 
DNA to form the nucleosome 
Table 1. Candidate substrates of Aurora A (modified from Li et al., Pharmacology & therapeutics, 2006). 
 
In contrast, the function and mode of action of another Aurora family member, 
Aurora B, is relatively clear when compared with Aurora A. Aurora B is a chromosome 
passenger protein that forms a complex with INCENP, survivin and Borealin (Gassmann 
et al., 2004; Sampath et al., 2004). It localizes to kinetochores from prophase to 
metaphase, and to the central spindle and midbody in anaphase and telophase 
(Carmena and Earnshaw, 2003). The kinase activity of Aurora B is activated by 
INCENP, which itself is also an Aurora B substrate. Aurora B is required for spindle 
checkpoint signaling (Giet and Glover, 2001), central spindle formation and cytokinesis 
(Giet and Glover, 2001). A number of substrates of Aurora B have been discovered, 
including CENP-A required for chromosome condensation (Zeitlin et al., 2001), MCAK 
(mitotic centromere associated kinesin) required for correcting the improper attachment 
of MTs to kinetochores (Andrews et al., 2004; Lan et al., 2004), MgcRacGAP, a 
GTPase activating protein required for cytokinesis (Hirose et al., 2001; Minoshima et al., 
2003) and MKlp1 (mitotic kinesin-like protein), which is also required for cytokinesis 
(Guse et al., 2005).  
                                                                                                                                                    Introduction                           
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MEN/SIN kinases? 
In budding yeast and fission yeast, a conserved signaling cascade known as 
mitotic-exit network (MEN) and septation-initiation network (SIN), respectively, controls 
key events during exit from mitosis and cytokinesis (Bardin and Amon, 2001). In higher 
eukaryotes, several kinases (Ndr/LATS family) are structurally related to a yeast 
SIN/MEN kinase (budding yeast Dbf2p/Mob1p and fission yeast Sid2p/Mob1p), but no 
functional homologies have yet been shown (Bardin and Amon, 2001; Nigg, 2001). 
Human Lats1 and Lats2 kinases have been implicated in regulating G1/S progression, 
cytokinesis and apoptosis, but the molecular pathways in which these kinases function 
remain to be clarified (Bothos et al., 2005; Li et al., 2003; Tao et al., 1999; Yang et al., 
2004). 
Aim of this thesis    
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Aim of this thesis 
The aim of this thesis has been to study the role of different kinases in mitotic 
progression. The thesis has been structured in two parts. In the first part, we explored 
the possible role of human Lats1 kinase in mitosis, mainly because of its close 
homology with the yeast Dbf2 kinase, which is involved in the mitotic exit network. We 
also studied its regulation by Ste20 like kinase Mst2, based on the fact that Lats has 
been shown to interact with Mst2 in Drosophila. In the second part, we turned to study 
the function and regulation of Aurora A kinase, by focusing on novel binding partners. 
We studied the interaction between Aurora A and hBora, a Aurora A activator originally 
identified in Drosophila. Our finding that hBora interacts with Aurora A and also another 
mitotic kinase, Plk1, then prompted us to study the regulation of Aurora A by Plk1 via 
hBora and their role in spindle assembly.  At the end, we investigated the function of 
Aurora A by siRNA mediated depletion and overexpression study. 
 
 











Part I: Basic characterization of human Lats1/2 kinases and 
their regulation by Ste20-like kinases Mst1/2 
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Introduction I 
LATS: a tumor suppressor gene 
The Drosophila melanogaster warts (wts) gene, also known as large tumor suppressor 
(lats), encodes a putative serine/threonine protein kinase. This gene was originally 
identified in two independent searches for loss of function mutants that gave rise to 
tissue overgrowth in flies (Justice et al., 1995; Xu et al., 1995). Two homologues genes 
were subsequently identified in mammals, named LATS1 and LATS2 (KPM) (Hori et al., 
2000; Nishiyama et al., 1999; Tao et al., 1999; Yabuta et al., 2000) . The human LATS1 
gene was able to rescue the Drosophila wts/lats mutant phenotype, arguing that it is a 
genuine orthologue of Drosophila wts/lats (Tao et al., 1999). Importantly, mammalian 
LATS1 displays properties of a tumor suppressor gene. Mice with a disrupted LATS1 
gene showed ovarian stromal cell tumors and an increased incidence of soft tissue 
sarcomas (St John et al., 1999). Moreover, LATS1 expression is reduced or absent in a 
number of human soft tissue sarcomas, suggesting that altered Lats1 levels might 
contribute to tumor formation also in human (Hisaoka et al., 2002). 
Proposed mitotic function of human Lats 
Concerning the cellular function of Lats kinases, two schools of thoughts have 
emerged, that do not have to be mutually exclusive. One proposed idea is that Lats 
plays a pivotal role during mitosis of the cell cycle. Based on the high homology of the 
Lats kinase domain with the yeast Dbf2 kinase family, a function of Lats1 during mitosis 
has been proposed. Saccharomyces cerevisiae Dbf2 is a component of the so-called 
mitotic exit network (MEN), which ensures proper chromosome segregation during 
mitosis. A number of other Dbf2 related kinases of various organisms have been 
implicated to function in diverse aspects of cell proliferation and morphogenesis. In 
human the closest Dbf2 and Lats homologs are the Ndr kinases, of which the functions 
are presently not known. Experimental evidence supporting a role for Lats1 in mitosis 
came with the observation that human Lats1 is a mitotic phospho-protein that could 
interact with the mitotic cyclin dependent kinase1 (Cdk1) during early mitosis (Tao et al., 
1999). Cdk1 bound to Lats1 was devoid of cyclin A and cyclin B and hence in an 
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inactive state. Moreover, Drosophila lats phenotypes could be suppressed by mutations 
in Cdc2 and Cyclin A and based on these findings it was suggested that Lats1 might 
negatively regulate cell cycle progression by inhibiting Cdk1 (Tao et al., 1999). 
Additional evidence supporting a role for Lats1 in mitosis came from the observation 
that human Lats1 localizes to the mitotic spindle (Morisaki et al., 2002; Nishiyama et al., 
1999). The role of Lats1 at the mitotic spindle is not known, but it has been proposed to 
play a role in targeting the focal adhesion protein, zyxin, to the spindle (Hirota et al., 
2000).  
Drosophila Lats is required for cell cycle exit and apoptosis 
Another view on Lats functioning has come from studies on eye imaginal disc 
development in Drosophila embryos. During retinal development, Drosophila wts/lats 
mutants showed a delayed cell cycle exit and an absence of the normally occurring 
apoptotic cell death (Tapon et al., 2002). Further inspection revealed increased levels of 
cyclin E and DIAP1 (Drosophila inhibitor of apoptosis 1) in these mutant cells. Based on 
these observations it was proposed that Drosophila Wts/Lats regulates developmentally 
controlled cell cycle exit and apoptosis. Such a dual function could readily explain the 
tissue overgrowth phenotype observed in wts/lats mutants. Mutations in two additional 
genes were recently shown to produce phenotypes that are very similar to those seen in 
wts/lats mutants. One of these genes, termed salvador (sav) (also named shar-pei), 
codes for a protein with two WW domains and a predicted coiled coil, suggesting that it 
may function as an adaptor (Kango-Singh et al., 2002; Tapon et al., 2002). The other, 
termed hippo (hpo), codes for a protein kinase of the Ste20-family (Harvey et al., 2003; 
Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003). Reminiscent 
of wts/lats mutants, mutations in either sav or hpo also resulted in delayed cell cycle 
exit, reduced apoptosis, and increased levels of cyclin E and DIAP1. This genetic 
evidence strongly suggested a functional link between the proteins encoded by hpo, wts 
and sav, and in support of this view, these Drosophila proteins could be shown to 
interact with each other (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; 
Udan et al., 2003; Wu et al., 2003) . Moreover, Hpo was able to phosphorylate both 
Wts/Lats and Sav, and the phosphorylation of Wts/Lats by Hpo was enhanced by the 
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presence of Sav (Pantalacci et al., 2003; Wu et al., 2003) . These data suggested that 
Wts/Lats, Sav and Hpo might form a trimeric complex in which Sav functions as an 
adaptor protein to bring Wts/Lats in close proximity to Hpo (Harvey et al., 2003).  
Putative orthologs of Drosophila Sav and Hpo are also present in mammals. 
Although little is known about the putative human Sav ortholog, hWW45, this gene was 
found to be mutated in a number of cancer cell lines (Tapon et al., 2002). The likely 
human orthologs of Drosophila Hpo are the Mst2 and Mst1 protein kinases, with 60 % 
and 58 % sequence identity, respectively. When expressed in Drosophila, Mst2 was 
able to rescue the hpo mutant phenotype, showing that it can act as a functional 
orthologue (Wu et al., 2003). The molecular function of Mst2 is not known, but the 
related Mst1 kinase was reported to induce apoptosis upon overexpression (Graves et 
al., 1998; Lee et al., 2001) . In addition, both Mst1 and Mst2 are substrates of caspase 
3. Thus, both Mst1 and Mst2 appear to be involved in apoptosis.  
Inspired by the above two models of Lats1 functioning, we decided to explore the 
expression, localization and regulation of human Lats1. Surprisingly, we could not 
confirm previous reports suggesting a role for Lats1 in mitosis, despite Lats1 being 
phosphorylated during this stage of the cell cycle. Interestingly, however, we found that 
Mst2 and hWW45 interact with each other in human cells and that both Mst2 and Mst1 
are able to phosphorylate Lats1 and Lats2, thereby stimulating Lats kinase activity. 
Detailed studies revealed that the activation of Lats1 by Mst2 results from the 
phosphorylation of two essential and highly conserved residues. From these data we 
conclude that Wts/Lats, Hpo/Mst2 and Sav/hWW45 form an evolutionary conserved 
regulatory module. The precise function(s) of this module remain to be unraveled but 
the available data point to a signal transduction pathway involved in controlling cell 
proliferation and apoptosis.  
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Results I 
LATS1 is ubiquitously expressed in contrast to LATS2 
To characterize the expression of the human LATS1 and LATS2 genes, cDNA panels 
(Clontech) of various human tissues were used. To distinguish between LATS1 and 
LATS2 expression a PCR based approach, with specific primer combinations, was used 
to survey these panels. Whereas LATS1 turned out to be ubiquitously expressed, 
LATS2 expression was limited to a small number of tissues and maximal expressions of 
LATS2 were observed in leukocytes, lung, pancreas and placenta (Fig. 7A). No obvious 
correlation between LATS1 and LATS2 expression and mitotic activity of the different 
organs could be established. A relatively high number of PCR amplifications was 
required for LATS2 detection (45 as compared to 35 for LATS1), suggesting that its 
expression is relatively low in comparison to LATS1. Examination of a cDNA panel of 
established human cell lines (Clontech) showed similar results (Fig. 7B), with relatively 
low LATS2 expression levels (Fig. 7B). Although LATS1 and LATS2 expressions have 
been investigated separately before (Hori et al., 2000; Tao et al., 1999; Yabuta et al., 
2000), this is the first direct comparison between LATS1 and LATS2 expression. Based 
on our results, indicating that LATS1 is expressed more ubiquitously and to higher 
levels than LATS2, we decided to focus our research primarily on the analysis of Lats1.  


























Figure 7. Expression profile of LATS1 and LATS2. 
(A) LATS1 is widely expressed in various tissues. PCR was performed on cDNA panels from Clontech 
using primers described in MATERIALS AND METHODS. 35 and 45 cycles were used for amplification 
of LATS1 and LAT2, respectively. The PCR products were then subjected to agarose gel 
electrophoresis, stained by ethidium bromide and visualized by UV exposure. G3PDH was used for 
normalization. (B) Ubiquitous expression of LATS1 in established cell lines. See (A).  
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Lats1 is phosphorylated during mitosis 
For investigating Lats1, a specific polyclonal antiserum against the N-terminal Lats1 
domain (aa 267 to 403) was raised. This affinity purified anti-Lats1 antibody recognized 
a single band at about 110kDa on Western blots of HeLaS3 cell lysates (Fig. 8A). No 
signal was observed when blots were probed with the corresponding pre-immune 
serum. Depletion of Lats1 by siRNA showed a strong diminishment of the 110 kDa 
band, confirming that this band represents the Lats1 protein (Fig. 8B). To examine the 
cell cycle regulation of Lats1, synchronized HeLaS3 cells obtained by different drug 
arrest-release protocols were used. In a first experiment, cells were released from a 
double aphidicolin block at the G1/S phase and samples were taken at regular intervals. 
Western blot analysis showed that Lats1 levels remained fairly constant during the cell 
cycle (Fig. 8C), but that part of Lats1 showed a slightly retarded mobility (upshift) at 
T=4-10 hours. This was coinciding with maximal expression of cyclin B1, indicating that 
Lats1 was phosphorylated during mitosis. This effect was even more pronounced when 
nocodazole blocked and released cells were investigated, reflecting the higher 
percentage of mitotic cells obtained by this method. The retarded electrophoretic 
mobility of Lats1 clearly paralleled the expression of cyclin B1 (Fig. 8D). The upshift was 
also observed in non-drug treated mitotic shake off cells indicating that this is not a 
drug-based artefact (Fig. 8D). Our results are consistent with a previous observation, 
showing a phosphorylation mediated upshift of Lats1 in nocodazole blocked and 
released mitotic cells (Tao et al., 1999). That Lats1 phosphorylation parallels cyclin B1 



















Figure 8. Characterization of the Lats1 antibodies and cell cycle profiles of Lats1.  
(A) Lats1 polyclonal antibodies recognize endogenous Lats1 protein. HeLaS3 cell extracts were 
immunoblotted by pre-immune IgG or affinity purified anti-Lats1 antibodies. Arrow represents endogenous 
Lats1. (B) Effective silencing of endogenous Lats1 upon siRNA treatment. HeLaS3 cells were transfected 
with siRNA duplex. Total cell extracts were harvested at the indicated time points and subjected to 
immunoblotting by anti Lats1 and α-tubulin antibodies. (C) Constants levels of Lats1 protein throughout 
the cell cycle and upshift during mitosis. HeLaS3 cells were synchronized by aphidicolin for 14 h. Then 
cells were released into fresh medium and harvested at the indicated time points. Cell extracts were then 
subjected to immunoblotting analysis by anti-Lats1 and α-tubulin antibodies. (D) Lats1 gets highly 
upshifted during mitosis. HeLaS3 cells were arrested in prometaphase by pre-synchronization with 
thymidine and subsequently nocodazole as described in MATERIALS AND METHODS. Cell extracts 
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Lats1 and Cdk1 do not interact in either coimmunoprecipitation or yeast two-
hybrid 
In support of the above possibility, it has been reported that Lat1 is a Cdk1/cyclin B1 
substrate. Surprisingly, though, it also has been reported that Lats1 can bind to and 
inhibit Cdk1 during early mitosis when it is in its phosphorylated form. This is difficult to 
reconcile with the observation that Cdk1/cyclin B1 is probably responsible for Lats1 
phosphorylation and we therefore tested this possible interaction between Cdk1 and 
Lats1. According to our results, we could not establish any interaction by either two-
hybrid analysis (Fig. 9A) or co-immunoprecipitation (Fig. 9B). Thus Lats1 is a mitotic 




Figure 9. No significant interaction between Lats1 and Cdk1 by yeast two-hybrid and 
coimmunoprecipitation. 
 (A) Yeast two-hybrid indicated the absence of Lats1 and cdk1 interaction. Full-length, C-terminal and N-
terminal of Lats1 in pGAD was transformed together with cdk1 in pGBD. Then the colonies were grown 
on minus leu, trp and ade plates for selection. (B) Cdk1 does not coimmunoprecipitate with Lats1 
throughout the cell cycle. HeLaS3 cells were synchronized by aphidicolin (lanes 4-6), nocodazole (lanes 
7-9) for 14 h and released from nocodazole for 90 min (lanes 10-12). Then cell extracts were prepared 
and used for immunoprecipitating endogenous Lats1 (upper panel). Coimmunoprecipitated complexes 




Result I                                                                                                              
22 
Lats1 shows a diffuse cytoplasmic staining throughout the cell cycle 
Previous studies had indicated that Lats1 localizes to the mitotic spindle (Hirota et al., 
2000; Nishiyama et al., 1999), suggesting a role for Lats1 during mitosis. To 
substantiate these findings we used our specific polyclonal Lats1 antibody to investigate 
Lats1 localization in HeLaS3 cells. In interphase cells this antibody showed a diffuse 
cytoplasmic staining throughout the cytoplasm, but no staining from the nucleus (Fig. 
10A, upper panels). In HEK293T and U2OS cells Lats1 staining was also diffuse 
throughout the cytoplasm, but also faint staining could be observed at cell-cell contacts 
(data not shown). The significance of the latter observation has so far not been further 
investigated. In all experiments the control pre-immune serum showed a significant by 
lower cytoplasmic staining (Fig. 10A, lower panels). Depletion of Lats1 by siRNA in 
HeLaS3 cells showed a significant decrease of the Lats1 cytoplasmic staining (Fig. 10B, 
lower panel), which was not observed in a control siRNA experiment with GL2 duplexes 
(Fig. 10B, upper panel). This clearly indicates that the observed cytoplasmic staining 
corresponds to Lats1 protein. This was further confirmed by expression studies of myc-
Lats1 and GFP-Lats1 that also both resided in the cytoplasm (Fig. 10C, data not 
shown). The Lats1 antibody readily detected these expressed tagged proteins, 
confirming once more that this antibody recognized Lats1 in cells (Fig. 10C).  To our 
surprise no co-localization of endogenous Lats1 was observed with spindle 
microtubules in mitotic cells (Fig. 10D). Instead a diffuse cellular staining was seen. 
Similar results were obtained when we investigated expressed myc- or GFP- tagged 
Lats1 in mitotic cells (Fig. 10E). In previous studies, Lats1 spindle staining was 
observed in cells that were first pre-permeabilized in microtubule stabilizing buffer, 
before fixation and staining (Hirota et al., 2000; Nishiyama et al., 1999). In contrast we 
used standard paraformaldehyde and methanol fixation procedures. Pre-
permeabilization obviously leads to loss of proteins from the cell and moreover could 
lead to re-localization of proteins. This might explain why in these former studies weak 


























Figure 10. Lats1 shows a cytoplasmic staining throughout the cell cycle. 
 (A) Cytoplasmic staining of endogenous Lats1 in both interphase and mitotic cells. Methanol-fixed 
HelaS3 cells were co-stained with α-tubulin (green) and α-Lats1 or pre-immune serum (red). DNA was 
visualized by DAPI (blue). (B) Lats1 siRNA treatment results in decreased cytoplasmic Lats1 levels. 
HeLaS3 cells were subjected to Lats1 and GL2 (as control) siRNA treatment for 48 h. Cells were then 
fixed and the levels of endogenous Lats1 were monitored with Lats1 (red), α-tubulin (green) and DNA 
(blue). (C) Myc and GFP-tagged Lats1 showed cytoplasmic straining. HeLaS3 cells were transiently 
transfected with GFP-Lats1 (right) or myc-Lats1 (left). Cells were fixed and labeled with Lats1 (green) and 
α-myc antibodies (red, for myc-transfection only) and DAPI (blue). (D) Endogenous Lats1 does not 
localize to the spindle. Methanol-fixed cells were labeled with Lats1 (red), α-tubulin (green) and DAPI 
(blue). (E) Cytoplasmic localization of overexpressed myc-Lats1 during mitosis. HeLaS3 cells transfected 
with myc-Lats1 for 24 h were assayed by labeling with myc (red) and α-tubulin (green). DNA is strained in 
blue with DAPI. 
 
Result I                                                                                                              
24 
Lats1 is absent from a spindle preparation 
To circumvent the problem that absence of staining never proves absence of protein, 
we resorted to biochemistry. Based on a previously published method (Sillje and Nigg, 
2006; Zieve and Solomon, 1982), we isolated mitotic spindles from HeLaS3 cells. The 
success of this isolation of mitotic spindles was verified by visualization of the spindles 
by differential interference contrast (DIC) light microscopy (Fig. 11A). To further validate 
the purification of these spindles, we compared samples prepared in the presence of 
taxol (microtubule stabilizing) or in the presence of nocodazole (microtubule 
destabilizing). Western blot analysis revealed that spindle components, including α-
tubulin, Plk1, Aurora A and TPX2 were present in samples prepared in the presence of 
taxol, but not in the presence of nocodazole, (Fig. 11B and data not shown). As 
anticipated from the immunofluorescence data, Lats1 could not be detected in these 
spindle preparations by Western blotting. Although we cannot exclude that Lats1 might 
be lost during the isolation procedure, we like to note that all known spindle proteins 
tested so far could be readily detected in these isolates. Together with the 
immunofluorescence microscopy results, the most straightforward interpretation is that 











Figure 11. No cofractionation of Lats1 with spindles.  
(A) Photo of isolated spindles. Spindles were prepared as described in MATERIALS AND METHODS. 
Isolated spindles were then visualized by differential interference contrast (DIC) light microscopy. (B) 
Lats1 is absent from the spindles preparation. HeLaS3 cells were synchronized by aphidicolin and, 
subsequently, taxol or nocodazole (as negative control) were used for isolating the spindles. The resulting 
spindles were subjected to immunoblotting by anti-Lats1, Plk1, α-tubulin antibodies.   
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Lats1 is active in okadaic acid (OA) treated cells, but not in mitotic cells 
Many kinases are controlled by reversible phosphorylation, and we therefore next asked 
whether the observed Lats1 phosphorylation during early mitosis would regulate Lats1 
kinase activity. Previously, no significant kinase activity measurements for Lats1 had 
been reported for any species, and indeed we found it difficult to measure Lats1 kinase 
activity. No good exogenous substrates for Lats1 could be found, suggesting that Lats1 
is not a promiscuous kinase but only phosphorylates a very limited number of 
physiological substrates. Lats1 showed, however, clear auto-phosphorylation, and we 
therefore relied mostly on this to attest Lats1 kinase activity (Fig. 12A). The endogenous 
Lats1 kinase activities of interphase and nocodazole-treated mitotic HeLaS3 cells were 
determined by in vitro kinase assays with immunoprecipitated endogenous Lats1 in the 
presence of [γ-32P]ATP. No significant kinase activities were observed in either 
asynchronous cells or nocodazole-treated mitotic cells (Fig. 12A). Thus Lats1 
phosphorylation during mitosis did not correlate with an increased kinase activity. 
Interestingly, however, treatment of cells with the PP1 and PP2A serine/threonine 
protein phosphatase inhibitor okadaic acid (OA) (Cohen et al., 1990) showed a marked 
increase in Lats1 kinase activity as shown by the appearance of a radioactive band at 
110 kDa (Fig. 12A). No radioactive bands were observed in immunoprecipitates with 
pre-immune IgG´s, indicating that this was Lats1 specific (Fig. 12A). A similar activation 
by OA has previously been reported for the homologues Ndr1 kinase, indicating that this 
family of Lats and Ndr kinases is regulated by reversible serine/threonine 
phosphorylation (Millward et al., 1999). As shown by Western blotting, OA treatment 
resulted in a more pronounced upshift of Lats1 as compared to nocodazole treatment, 
indicating that distinct or additional serine or threonine residues are phosphorylated in 
the presence of OA that contribute to Lats1 activation.  
To corroborate these findings, myc tagged Lats1 wildtype (WT) and a 
catalytically inactive kinase dead (KD) mutant, containing a mutation changing the 
conserved aspartate in subdomain VII into alanine (D846A), were transiently expressed 
in HEK293T cells. After treatment of these cells with nocodazole, OA, or nothing, these 
recombinant proteins were immunopurified, using anti-myc 9E10 beads, and used in in 
vitro kinase assays. Again, significant Lats1 kinase activity was observed only in 
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immunoprecipitates from OA treated cells (Fig. 12B). No activity was observed under 
any of these conditions with the myc-Lats1KD mutant (Fig. 12B), excluding the 
possibility that the observed phosphorylation of Lats1 could be attributed to co-
precipitating kinases. During the course of this study it was reported that Lats1 could be 
slightly activated upon release from a nocodazole block for 10-20 min in Rat1 cells (Iida 
et al., 2004). To test this in vitro kinase assays were performed on myc-Lats1WT and 
KD immunoprecipitates from nocodazole blocked and released HEK293T cells. In 
contrast to what has been reported previously, we did not observe any significant 
increase in Lats1 activity in nocodazole released cells as compared to OA induced 
activation (Fig. 12C). Altogether our data show that despite being phosphorylated during 
mitosis, mitotic Lats1 does not contain significant kinase activity. Lats1 was however 
strongly activated by OA treatment, suggesting that serine/threonine phosphorylation is 














Figure 12. Activation of Lats1 kinase activity by okadaic acid (OA). 
 (A) In vivo activation of Lats1 kinase by okadaic acid (OA). HeLaS3 cells were treated with nocodazole 
for 14 h or 1 μM OA for 1 h and HEPES cell extracts were prepared. Endogenous Lats1 was then pulled 
down and kinase activities were detected by in vitro kinase assay. Levels of immunoprecipitated Lats1 
protein were confirmed by Western blotting. Pre-immune IgG pull down was used as a negative control. 
(B) Overexpressed Lats1 can be activated by okadaic acid. HEK293T cells were transiently transfected 
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with either myc-Lats1WT or KD for 24 h, before cells were treated with OA for 1 h or blocked by 200 ng/ml 
nocodazole for 14 h and released from prometaphase. Cell extracts were then prepared at the indicated 
time points. Kinase activities of the myc-immunoprecipitates were assayed and detected by 
autoradiography. Western blot was performed to check the levels of myc-Lats1. (C) No significant Lats1 
activities were detected during mitosis when compared with OA treated cells. The kinase activities of 
overexpressed Lats1 were examined as in (B) while nocodazole treated cells were also released into 
fresh medium for 15 min and 30 min before harvesting. 
Mst2 interacts with hWW45 
Although a mitotic modification of Lats1 could be confirmed, previously reported spindle 
association and Cdk1 interaction could not be reproduced. Hence, we next turned to 
explore the possible interaction between human Lats1, hWW45 and Mst2 kinase, as 
described for the purported respective homologues in Drosophila (Wts, Sav and Hpo). 
To explore possible in vivo interactions between human Lats1, hWW45 and Mst2, the 
three proteins were epitope-tagged and co-expressed in HEK-293T cells. FLAG-Mst2 
was then immunoprecipitated with anti-FLAG antibody and co-precipitation of hWW45 
or Lats1 was assessed by Western blotting. In FLAG-Mst2 immunoprecipitates, GFP-
tagged hWW45 could readily be detected, indicating that these two proteins are able to 
form a complex (Fig. 13A). No interaction was observed between GFP-hWW45 and an 
unrelated FLAG-tagged protein (FLAG-Ect2), demonstrating that the Mst2-hWW45 
interaction was specific (Fig. 13B). Myc-Lats1, on the other hand, could not be detected 
in Mst2 immunoprecipitates, regardless of whether or not GFP-hWW45 was co-
expressed (Fig. 13A). Similarly, in a reciprocal experiment, both FLAG-Mst2 and GFP-
hWW45 were absent from myc-Lats1 immunoprecipitates (Fig. 13C). Thus, under the 
experimental conditions used here, human Lats1 did not stably interact with either 
hWW45 or Mst2. To corroborate these results and map the interaction domains 
between Mst2 and hWW45, yeast two-hybrid assays were performed. Supporting the 
results of the co-immunoprecipitation experiments, a yeast-two hybrid interaction could 
be demonstrated between Mst2 and hWW45 (Fig. 13D, upper panel), and this 
interaction required the C-terminal halves of the two proteins (Fig. 13D, lower panel). In 
contrast, no interaction could be detected between Lats1 and either Mst2 or hWW45, 
regardless of whether full-length Lats1 or Lats1 domains were used (Fig. 13D, upper 
panel and data not shown). Results were independent of whether the proteins were 
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fused to the Gal4 DNA-binding or activation domains (data not shown). Taken together, 
these experiments indicate that Mst2 and hWW45 are able to form a stable complex in 
vivo. In contrast, no stable interaction could be observed between either Mst2 or 

















Figure 13. Mst2 interacts with hWW45.  
(A) HEK293T cells were co-transfected with plasmids expressing myc-Lats1, FLAG-Mst2 and GFP-
hWW45, as indicated. Cell lysates (left) and FLAG-Mst2 immunoprecipitates (right) were immunoblotted 
(WB) with antibodies against FLAG, myc and GFP. (B) GFP-hWW45 was co-expressed with FLAG-Mst2 
or FLAG-Ect2 (negative control). FLAG-immunoprecipitates were subsequently probed with antibodies 
against FLAG and GFP (C) Experiment as described under A, except that myc-Lats1 was 
immunoprecipitated with anti-myc 9E10 beads. (D) Yeast two-hybrid analysis with full-length Lats1, Mst2 
and hWW45 proteins (upper panel) or with N- and C-terminal domains of Mst2 and hWW45 (lower panel). 
Interactions were reflected by growth on selective plates (-LWA) (right).  For control, growth on non-
selective plates (-LW) is shown (left). 
Lats1 is phosphorylated by Mst2 
In a next series of experiments, recombinant Lats1, Mst2 and hWW45 were produced 
by in vitro coupled transcription translation (IVT) and interactions were explored by co-
immunoprecipitation experiments. Myc-hWW45, but not myc-Lats1, could be co-
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immunoprecipitated with FLAG-Mst2 (Fig. 14A, right panel), confirming and extending 
the results shown in Figure 13. Most interestingly, however, these experiments also 
revealed that co-translation with FLAG-Mst2 resulted in an upshift of myc-Lats1 in SDS-
PAGE (Fig. 14A, left panel), suggesting that Mst2 could cause Lats1 phosphorylation in 
the lysates. To further examine this possibility, both wild-type (WT) and catalytically 
inactive (kinase dead; KD) mutants of Lats1 and Mst2 were expressed individually in 
HEK293T cells. After immunopurification of the proteins via their myc- (Lats1) or FLAG- 
(Mst2) tags, in vitro kinase assays were carried out in the presence of [γ-32P]ATP. 
Substantial incorporation of 32P into myc-Lats1WT and KD proteins could be seen 
following incubation with FLAG-Mst2WT but not FLAG-Mst2KD (Fig. 14B). In contrast, 
although FLAG-Mst2WT appeared to undergo autophosphorylation, no phosphorylation 
of FLAG-Mst2KD proteins by myc-Lats1WT could be detected (Fig. 14B). Thus, Mst2 
could clearly phosphorylate Lats1, at least in vitro. These data also indicate that the 
presence of hWW45 was not required for phosphorylation of Lats1 by Mst2.  
 
 
Figure 14. Mst2 phosphorylates Lats1 in vitro.
(A) Myc-Lats1, FLAG-Mst2 and myc-hWW45 
were produced in different combinations by IVT in 
the presence of 35S methionine. Flag-Mst2 was 
subsequently immunoprecipitated and IVT input 
(left) and FLAG-immunoprecipitates (right) were 
analysed by SDS-PAGE followed by 
autoradiography. (B) Immunopurified myc-
Lats1WT or KD (on beads) and FLAG-Mst2WT or 
KD (in solution) were mixed in different 
combinations in Lats1-kinase buffer in the 
presence of [γ-32P]ATP, as indicated. Kinase 
reactions were analysed by SDS-PAGE followed 
by autoradiography. Western blotting with anti-
myc 9E10 and FLAG antibodies confirmed the 
presence of myc-Lats1 and FLAG-Mst2 proteins. 
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Lats1 is activated by Mst2 -mediated phosphorylation 
Next, we asked whether phosphorylation by Mst2 would lead to activation of the Lats1 
kinase. It proved difficult to find an exogenous substrate for measuring Lats1 kinase 
activity, which probably indicates that Lats kinases phosphorylate only a limited number 
of physiological substrates. However, Lats1 WT was found to auto-phosphorylate, which 
made it possible to use autophosphorylation as a read-out for Lats1 kinase activity. To 
determine the effect of Mst2 phosphorylation on Lats1 activity, immobilized myc-
Lats1WT or KD proteins were phosphorylated by pre-incubation with soluble FLAG-
Mst2WT in the presence of non-radioactive ATP. As negative controls, myc-Lats1 
proteins were incubated in parallel with FLAG-Mst2KD. Subsequently, FLAG-Mst2 
proteins were removed by extensive washing and myc-Lats1 proteins were incubated 
for autophosphorylation to occur in the presence of radioactive [γ-32P]ATP. After pre-
phosphorylation by FLAG-Mst2WT, myc-Lats1WT showed strong autophosphorylation 
activity, whereas the activity of the same protein pre-incubated with FLAG-Mst2KD was 
barely detectable (Fig. 15A). No incorporation of 32P could be observed into myc-
Lats1KD proteins, demonstrating that FLAG-Mst2 kinase had been effectively removed 
prior to the addition of [γ-32P]ATP (Fig. 15A). These results clearly show that Mst2-
mediated phosphorylation stimulates the in vitro kinase activity of Lats1.  
To extend these findings to an in vivo situation, myc-Lats1WT and KD were co-
expressed with FLAG-Mst2WT or KD in HEK293T cells. Then, myc-Lats1 kinases were 
immunoprecipitated and the associated activities determined. Strong stimulation of myc-
Lats1WT kinase activity could be observed upon co-expression with FLAG-Mst2WT, but 
not with FLAG-Mst2KD (Fig. 15B). No significant activities were associated with myc-
Lats1KD proteins, ruling out the presence of co-precipitating kinases. Moreover, 
Western blot analyses showed the absence of contaminating FLAG-Mst2 proteins (Fig. 
15B). We conclude that Mst2 is able to activate Lats1 kinase also in vivo.  





















Figure 15. Mst2 activates Lats1 both in vitro and in vivo.  
(A) Myc-Lats1WT or KD proteins immunopurified from IVT reactions (on beads) were mixed with equal 
amounts of soluble FLAG-Mst2WT or KD isolated from HEK293T cells. These proteins were pre-
incubated for 30 min at 30°C in the presence of 10 μM ATP, after which the FLAG-Mst2 proteins were 
washed away. The myc-Lats1 beads were then used for kinase assays in the presence of  [γ-32P]ATP. 
After SDS-PAGE, Lats1 autophosphorylation was visualized by autoradiography. Western blotting 
revealed that similar amounts of myc-Lats1 proteins were recovered after washing. (B) Myc-Lats1WT or 
KD was expressed in HEK293T cells together with FLAG-Mst2WT or KD, as indicated. Myc-Lats1 
proteins were immunoprecipitated with anti-myc 9E10 beads and used for in vitro kinase assays. After 
SDS-PAGE, Lats1-autophosphorylation was visualized by autoradiography. Western blot analysis 
confirmed equal expression levels (co-expression). Moreover, equal amounts of myc-Lats1 proteins were 
recovered by immunoprecipitation and these precipitates were devoid of residual FLAG-Mst2 proteins 
(Myc-IP). 
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Specific activation of Lats1 and Lats2 by Mst2/1 kinases 
Considering the extensive sequence homology between human Lats1 and Lats2, we 
asked whether Mst2 could also activate Lats2. Myc-Lats2WT and KD proteins were 
prepared by IVT, together with either FLAG-Mst2WT or KD. Then, myc-Lats proteins 
were immunoprecipitated, washed free of Mst2, and subjected to kinase assays. For 
comparison, myc-Lats1WT and KD were analyzed in parallel. FLAG-Mst2WT, but not 
KD, could readily stimulate the auto-phosphorylation activity of both myc-Lats1 and -
Lats2WT proteins (Fig. 16A, upper panel). Although 32P incorporation into myc-Lats2 
was lower than that into myc-Lats1, this can be attributed to a difference in the 
corresponding protein levels, as shown by Western blotting (Fig. 16A, lower panel). 
Thus, Mst2 is clearly able to activate both Lats1 and Lats2.   
Mst2 belongs to a kinase family that comprises several members. Although Mst2 
is most closely related to Drosophila Hpo and capable of functional complementation 
(Wu et al., 2003), it seemed possible that other Mst family members could carry out 
similar functions. We therefore tested two additional Mst kinases for their ability to 
activate Lats kinases in vitro, notably Mst1, a close homologue of Mst2, and Mst4, a 
more distant family member implicated in cell migration and polarization (Preisinger et 
al., 2004). Using the IVT assay described above, we found that both FLAG-Mst2 and 
Mst1 were able to activate myc-Lats1, whereas Mst4 produced little, if any, activation 
(Fig. 16B, top row). As judged by their ability to incorporate 32P through 
autophosphorylation, all FLAG-MstWT kinases were similarly active, whereas the 
corresponding KD mutants were inactive (Fig. 16B, second row). Recovery of the myc-
Lats1 protein and the various FLAG-Mst proteins was monitored by Western blotting 
(Fig. 16B, bottom rows). These results show that Mst2 and Mst1 can activate Lats1, 
whereas a more distant family member, Mst4, displays little, if any, activity.  


























Figure 16. Lats kinases are specifically activated by Mst1 and Mst2.  
(A) The indicated myc-Lats proteins were co-expressed by IVT together with FLAG-Mst2WT or KD. They 
were then immunopurified and used for in vitro kinase assays in the presence of [γ-32P]ATP. After SDS-
PAGE, Lats autophosphorylation was visualized by autoradiography. Western blotting of the 
immunoprecipitates with anti-myc 9E10 antibodies, showed lower levels of myc-Lats2 as compared to 
myc-Lats1. (B) Myc-Lats1WT or KD proteins were co-expressed by IVT together with the indicated FLAG-
Mst proteins. They were then immunopurified and used for in vitro kinase assays as described above. In 
parallel, FLAG-Mst proteins were immunopurified with anti-FLAG M2 beads and used for in vitro 
autophosphorylation assays to determine their relative kinase activities. Western blot analysis confirmed 
recovery of Lats and Mst proteins.  
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The Lats1 activation segment resides in the C-terminal (catalytic) domain 
The above data are consistent with a model according to which Mst2 phosphorylates 
and activates Lats1 not only in vitro but also in vivo. To explore the mechanism 
underlying Lats1 activation, several myc-tagged Lats1 deletion constructs were 
generated (Fig. 17A). To determine which of these Lats1 deletion mutants could still be 
regulated by Mst2, they were then produced by IVT together with FLAG-Mst2WT or KD, 
immunoprecipitated and tested for activity. A construct lacking the N-terminal 588 
residues was activated almost to the same extent as the Lats1WT protein, indicating 
that the entire N-terminal half of Lats1 was dispensable for its activation by Mst2 (Fig. 
17B). Further deletion of N-terminal sequences, up to residue 662, resulted in a kinase 
that could not be regulated by Mst2, although it displayed some basal activity (Fig. 17B). 
We conclude that Mst2 can still regulate a fragment of Lats1 encompassing residues 
589-1130 and that removal of residues 589-662 abolishes this response. Remarkably, 
neither the N-terminally located putative UBA domain, a structure believed to bind 
ubiquitin moieties (Buchberger, 2002), nor the PPXY motifs, previously implicated in 
mediating the interaction between Wts/lats and Sav in Drosophila (Tapon et al., 2002), 
were required for this regulation.  
 We have previously shown that Lats1 was mainly present in an inactive state in 
cells, but could be readily activated upon treatment of cells with okadaic acid (OA) (Fig. 
12). This afforded the interesting possibility to investigate the in vivo activation of the 
different Lats1 protein fragments. HEK293T cells were therefore transiently transfected 
with the various Lats1 constructs and subsequently treated with OA or solvent, before 
the myc-Lats1 proteins were immunopurified and analyzed for activity. In excellent 
agreement with the results obtained in vitro, the mutant lacking the first N-terminal 588 
residues was still fully activated by OA, whereas further removal of residues up to amino 
acid 662 resulted in a non-responsive kinase (Fig. 17C). Thus, activation of Lats1 
mutants by Mst2 in vitro and by OA in vivo displays the same structural requirements. 
This congruence strongly supports the notion that Mst2 acts directly upstream of Lats1 
in OA-treated cells.   





























Figure 17. Identification of a Lats1 activation segment in the C-terminal domain.  
(A) Schematic diagram showing different Lats1 deletion constructs with numbers denoting amino acids. 
Shown are a putative UBA domain in grey, two PPXY motifs in black and the kinase domain as a striped 
box. (B) Myc-tagged Lats1 constructs were co-expressed by IVT together with FLAG-Mst2WT or KD. 
Following immunoprecipitation they were used for in vitro kinase assays in the presence of [γ-32P]ATP. 
Autophosphorylation of Lats1 was visualized by autoradiography. Western blot analysis confirms recovery 
of similar amounts of myc-Lats1 proteins.  (C) HEK293T cells were transfected for 24 h with myc-tagged 
Lats1 constructs and then treated for 1 h with 1 μM of okadaic acid (OA) or ethanol (solvent for OA). Myc-
Lats1 proteins were immunoprecipitated and their activities determined as described above. Western 
blotting shows equal recovery. 
Result I                                                                                                              
36 
Phosphorylation of S909 and T1079 is essential for Lats1 kinase activity 
To identify the phosphorylation sites involved in Lats1 regulation, the smallest regulated 
Lats1 kinase fragment identified above (myc-Lats1NΔ588WT) was phosphorylated in 
vitro with FLAG-Mst2WT. To distinguish sites phosphorylated by Mst2 from those 
modified through Lats1 autophosphorylation this fragment was also incubated with 
FLAG-Mst2KD and a corresponding inactive mutant (myc-Lats1NΔ588KD) was 
incubated with both Mst2WT and Mst2KD. All samples were then subjected to extensive 
analysis by mass spectrometry performed by Dr. M. Nousiainen. These studies resulted 
in the identification of 11 phosphorylation sites within myc-Lats1NΔ588WT. 
Representative of these data, Figure 18 illustrates the ion scans allowing the 
identification of two particularly relevant sites (serine (S) 909 and threonine (T) 1079), 
whereas Figure 19 summarizes all results in schematic form. Three sites (S613, S633 
and S1111) were phosphorylated in all samples, indicating that they were already 
occupied prior to the isolation of the myc-Lats1 proteins from HEK293T cells (Fig. 19). 
As these sites do not appear to contribute directly to the Lats1 kinase regulation by 
Mst2, they were not further investigated. Similarly, since Mst2 can activate both Lats1 
and Lats2, three phosphorylation sites (S674, T1012 and S1049) present in Lats1 but 
absent from Lats2 were considered unlikely to constitute important regulatory sites. This 
left a total of five sites (S872, S909, T967, T1060 and T1079) for further investigation 
(Fig. 19).  









Figure 18. MS profiles of Lats1-derived tryptic peptides.  
Shown are MALDI-TOF spectra, acquired in negative ion mode, of tryptic digests of myc-Lats1NΔ588WT 
treated with either FLAG-Mst2WT or KD. The selected mass ranges show the peaks originating from the 
unphosphorylated and phosphorylated peptides. Left panels (A-C) show the peptide comprising S909 and 
right panels (D-F) show the peptide containing T1079. Myc-Lats1NΔ588WT was treated with FLAG-
Mst2WT (spectra A and D) or KD (spectra B and E). The exact phosphorylation sites were localized 
through fragmentation of the phosphorylated peptides by nanospray ionization Q-TOF mass spectrometry 










Figure 19. Schematic summary of the phosphorylation-sites identified in Lats1.  
Myc-tagged Lats1NΔ588WT or KD and FLAG-Mst2 WT and KD were purified from HEK293T cells and 
incubated in different combinations in the presence of 10 μM ATP. Sites phosphorylated in the myc-
Lats1NΔ588 proteins were then identified by mass spectrometry. Filled circles refer to phosphorylated 
residues, whereas open circles indicate absence of detectable phosphorylation. The bottom row indicates 
whether (+) or not (-) the relevant residues are conserved in Lats2. * = This site could not be 
phosphorylated by Mst2 in the D846A mutant, but could be phosphorylated in another Lats1KD mutant 
(T1079A). Myc-Lats1KD mutants. ** = not strictly conserved but neighboring threonine present. 
 
To explore the functional significance of these five sites, they were individually 
mutated to alanine (A), thus mimicking an unphosphorylated state. The S872A, S909A, 
T967A, T1060A and T1079A mutant proteins were produced by IVT, together with 
either FLAG-Mst2WT or KD, and after isolation by immunoprecipitation, their kinase 
activities were determined (Fig. 20A). Three of the mutants, S872A, T967A and 
T1060A, could still be activated by Mst2 to a similar extent as myc-Lats1WT.  In 
contrast, the S909A and T1079A mutants could not be activated (Fig. 20A). This 
suggested that phosphorylation at both of these sites is required for Lats1 kinase 
activation. To examine whether acidic charges at these sites might be sufficient to 
confer activation, S909 and T1079 were mutated to glutamate (E) or aspartate (D), 
either individually or in combination. Neither S909D (or E) nor T1079D (or E) mutant 
proteins showed significant activity when produced in the presence of FLAG-Mst2KD 
(Fig. 20B, C). However, co-expression with FLAG-Mst2WT resulted in the activation of 
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both the T1079D and the T1079E proteins (Fig. 20C), whereas the S909D or E mutants 
proved refractory (Fig. 20B). Mutants carrying acidic residues at both S909 and T1079 
did not show any activity and could not be activated (data not shown). Thus, 
phosphorylation of T1079 seems to be necessary but not sufficient for Lats1 activation. 
Although the S909D or E mutants could not be activated by FLAG-Mst2WT (Fig. 20B), it 
should be noted that the S909 residue is located within the activation loop and that 
there are strong precedents of kinase regulation by activation-loop phosphorylation 
(Johnson et al., 1996). It appears that phosphorylation at S909, in addition to 
phosphorylation at T1079, is required for Lats1 activation, but that substitution of the 

















Figure 20. Phosphorylation of S909 and T1079 is essential for Lats1 kinase activation.  
(A) The indicated myc-Lats1 mutants were expressed by IVT together with FLAG-Mst2WT or KD. Myc-
Lats1 proteins were then immunoprecipitated and used for in vitro kinase assays in the presence of [γ-
32P]ATP. Proteins were subjected to SDS-PAGE and autophosphorylation activity visualized by 
autoradiography. (B) The indicated myc-Lats1 mutants, as well as the WT and KD kinases, were 
expressed by IVT, together with FLAG-Mst2WT or KD and used for in vitro kinase assays, as described 
above. (C) The indicated myc-Lats1 mutants, as well as WT and KD kinases, were expressed by IVT 
together with FLAG-Mst2WT or KD and used for in vitro kinase assays, as described above. Western 
blotting in A-C shows equal protein recovery.  
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Discussion I  
Lats (Wts) kinases have been implicated in the regulation of cell cycle progression and 
apoptosis. Recent genetic studies in Drosophila have shown that Lats/Wts kinases 
interact with two other proteins termed Salvador (Sav) and Hippo (Hpo) (Harvey et al., 
2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003). This 
raised the question of how exactly these proteins cooperate to form a signaling module, 
and how they are regulated at a molecular level. Furthermore, proteins structurally 
related to Drosophila Lats, Sav and Hpo have also been described in mammals, but no 
functional interactions between these proteins have been previously reported. Here we 
have shown that human Lats1 forms a signaling module with Mst2 and hWW45, the 
putative human homologs of Drosophila Hpo and Sav, respectively. Specifically, our 
data show that Mst2 phosphorylates Lats1 on two critical residues, identified as S909 
and T1079, respectively. These phosphorylations result in Lats1 kinase activation, 
demonstrating that the Ste20-like kinase Mst2 functions as an upstream activator of 
Lats1. The WW protein hWW45 was not required for the phosphorylation and activation 
of Lats1 by Mst2 Although this protein could not be shown to interact with Lats1, it was 
clearly able to bind Mst2. Taken together with recent results from Drosophila, these data 
provide strong evidence for the evolutionary conservation of a signaling module 
comprising Lats(Wts) kinase, a Ste20-like upstream regulatory kinase (Mst2/Hpo), and 
a WW protein (hWW45/Sav). Evidence for a mitotic role of Lats1 was not obtained, 
suggesting that the original findings supporting a role for Lats1 in mitosis need to be 
reevaluated. Although we cannot rigorously exclude possible mitotic functions, our 
observation that Lats1 is part of a conserved signal transduction pathway, points to 
other roles for human Lats1, in analogy to Drosophila Wts. 
Ste20 family members as upstream regulators of Lats/Dbf2-related kinases 
Our biochemical studies demonstrate an enzyme-substrate relationship between 
human Mst2 and Lats1, confirming and extending previous data on Drosophila Hpo and 
Lats (Pantalacci et al., 2003; Wu et al., 2003) . In addition, we found that Mst2 was able 
to phosphorylate and activate not only Lats1 but also the related kinase Lats2. 
Moreover, Mst1 could also activate Lats1, but Mst4, a more distantly related Mst family 
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member, could not. Thus, the activation of Lats1/2 kinases by Mst family members 
displays specificity. Most importantly, co-expression experiments indicate that Mst2 can 
also activate Lats1 in vivo and treatment of cells with the phosphatase inhibitor OA, a 
potent activator of Mst1/2 (Lee et al., 2001; Taylor et al., 1996), also resulted in 
activation of Lats1. This in vivo activation showed the exact same requirements for a C-
terminal Lats1 domain that had been inferred from in vitro activation studies with 
recombinant Mst2 and Lats1 proteins. Taken together, these data strongly suggest that 
Mst2 is a direct upstream activator of Lats1.  
Since the N-terminal half of Lats1 (aa 1-588) was dispensable for the activation 
of Lats1 by Mst2, mass spectrometry was used to identify phosphorylation sites within 
the C-terminal domain of Lats1. A total of 11 sites were identified and five sites, all of 
which are conserved in Lats2, could be shown to be phosphorylated by Mst2. Two of 
these, S909 and T1079, were required for Lats1 activation. Interestingly, these sites are 
located within the activation loop (S909) and a hydrophobic motif (T1079), two domains 
previously been implicated in the activation of other kinases (Johnson et al., 1996; 
Tamaskovic et al., 2003). In particular, the sequences flanking S909 and T1079 are 
highly conserved not only in Lats kinases, but also in families of structurally related 
kinases, exemplified by human Ndr1 and Saccharomyces cerevisiae Dbf2p 
(Tamaskovic et al., 2003). Much like Lats, yeast Dbf2p kinase is also regulated by a 
member of the Ste20 kinase family, Cdc15p (Tamaskovic et al., 2003). Moreover, 
human Ndr1 is phosphorylated on S281 and T444 (Millward et al., 1999), two residues 
corresponding to S909 and T1079 of Lats1. Thus, it is attractive to speculate that Ndr1 
may also be subject to regulation by a Ste20-like kinase.  
Ste20-like Mst family members are unlikely to be the only kinases acting on 
Lats1. In a previous study, Lats1 was shown to be phosphorylated and upshifted during 
M phase of the cell cycle (Tao et al., 1999). We have confirmed this observation but 
found that this phosphorylation does not result in enhanced autophosphorylation activity 
(Fig 10). Moreover, whereas phosphorylation of Lats1 by Mst2 in vitro caused a clear 
upshift, no significant upshift was seen upon co-expression of Lats1 with Mst2 in vivo, 
presumably because of phosphatase action. Yet, Lats1 kinase activity was enhanced 
under both conditions, indicating that a retarded electrophoretic mobility cannot be used 
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as a reliable indicator of Lats1 activity. Interestingly, OA treatment of Lats1-transfected 
cells resulted in an upshift in case of the Lats1 WT protein but not the Lats1 KD mutant, 
indicating that autophosphorylation can give rise to a retarded electrophoretic mobility. 
In nocodazole-arrested mitotic cells, Cdk1 and Aurora A kinases could be responsible 
for causing an upshift of Lats1, although the consequences of these phosphorylations 
remain to be clarified (Morisaki et al., 2002; Toji et al., 2004). 
What is the role of hWW45 in the regulation of Lats kinases? 
Following up on the recent identification of the WW protein, Sav, in Drosophila, 
we have also explored the role of the apparent human Sav homolog, hWW45. Our 
experiments concur to demonstrate that hWW45 and Mst2 are able to form a complex. 
In contrast, no evidence could be obtained for stable binding of either Mst2 or hWW45 
to Lats1, and no ternary complexes were observed. At first glance, this appears to 
contrast with results obtained in Drosophila, where Sav (hWW45) was shown to interact 
with Lats (Tapon et al., 2002) and enhance its phosphorylation by Hpo (Pantalacci et 
al., 2003; Wu et al., 2003) . We cannot definitively explain this difference, but note that 
the Drosophila studies made use of a Sav fragment, comprising the WW domain, 
whereas the present study was carried out with the full-length hWW45 protein. This 
raises the intriguing possibility that the interaction of full-length Sav/hWW45 with 
Lats1/Lats is subject to regulation.  
  Observations made in Drosophila have led to the proposal that Sav could 
function as a scaffold for the formation of a trimeric complex (Harvey et al., 2003). This 
proposal is attractive, but the existence of a trimeric complex between Lats1/Lats, 
Mst2/Hpo and hWW45/Sav remains to be demonstrated and alternative scenarios 
should not be excluded. Although the PPXY motifs located in the N-terminal half of Lats 
have been implicated in mediating the interaction between Lats and Sav in Drosophila 
(Tapon et al., 2002), we found that these motifs were dispensable for the activation of 
human Lats1 by both Mst2 in vitro and OA in vivo. Thus, we presently favor a model 
according to which hWW45 (Sav) functions primarily as a regulator of Mst2 (Fig. 21).  
Interestingly, the interaction between the C-termini of Mst2 and hWW45 may 
involve a motif, termed SARAH (Sav/Rassf/Hpo), that appears to function as a modular 
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protein-protein interaction domain (Scheel and Hofmann, 2003). A SARAH motif is also 
present in proteins of the Rassf family, the founding member of which is encoded by the 
tumor suppressor gene RASFF1 (Dammann et al., 2000). These proteins harbor a Ras-
association domain (hence their name: ras association domain family) and are believed 
to act in signal transduction pathways. Although the exact functions of Rassf proteins 
remain to be unraveled, roles in cell cycle progression and apoptosis have been 
proposed (Khokhlatchev et al., 2002; Song et al., 2004). Moreover, Rassf family 
members Rassf1 and Nore1/Rassf5 have recently been shown to interact with Mst1, 
and to inhibit Mst1 auto-activation in vitro (Praskova et al., 2004). Thus, it will be 
interesting to explore the possibility that Rassf proteins could attribute to the regulation 




Figure 21. The hWW45-Mst2-
Lats1 signal transduction 
module. 
This model incorporates data 
described here for human 
proteins and elsewhere for 
Drosophila homologs Sav, 
Hpo, and Wts. The activation 
of Lats1 by Mst2 has only 
been shown in human cells
(this study), but considering 
the extensive sequence 
similarity, is likely to represent 
an evolutionarily conserved 
mechanism. For simplicity, 
Mst1 and Lats2 are not shown 
in this model. 
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Emerging evidence for an evolutionarily conserved signaling pathway 
Pioneering work performed in Drosophila provides strong evidence that the Lats-
Hpo-Sav module plays a key role in regulating cell cycle exit and apoptosis during 
development (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 
2003; Wu et al., 2003) . Here we have shown that a very similar signaling module is 
operating in human cells (Fig. 21). Gene disruption experiments performed in mice 
support a critical role of Lats kinases in tumor suppression (St John et al., 1999), and 
recent studies point to diverse roles of human Lats kinases in cell cycle progression (Li 
et al., 2003; Yang et al., 2001) , cytokinesis (Yang et al., 2004) and the induction of 
apoptosis (Yang et al., 2001).  However, the precise roles of mammalian Lats kinases 
remain to be clarified. Moreover, with at least two similar Mst kinases acting on two 
closely related Lats kinases, the situation in human cells is expected to be more 
complex than in Drosophila.  
In summary, our present data demonstrate the evolutionary conservation of a 
signaling module in which Lats kinases are downstream effectors of a complex 
comprising Mst kinases and hWW45 (Fig. 21). Combined biochemical and genetic 
investigations, will hopefully soon lead to the further delineation of this pathway that is 
likely to be important for development and homeostasis.  
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Summary I 
In the first part of this thesis, we have investigated the possible role of Lats1 kinase in 
mitosis.  Our data does not support the reported role of human Lats1 in mitosis. Instead, 
we showed that Lats1 activity is regulated by Mst2 kinase, demonstrating the 
evolutionary conservation of a Lats/Mst/hWW45 pathway, which is required for 
controlling cell size and growth in Drosophila. Because the research interest of our 
department is on kinases that play essential role in mitosis and the mitotic function of 
Lats1 does not seem to be promising, I then changed my project and set out to study 
the function of Aurora A kinase, focusing on possible interaction partners.  
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Part II: Exploring the function and regulation of  
Aurora A kinase 




Centrosome maturation in mitotic spindle assembly 
The spindle apparatus, a bipolar array of highly dynamic microtubules (MTs), is 
indispensable for accurate sister chromatid segregation during mitosis. Its precise 
regulation in time and space is critical for genome stability. Moreover, spindle 
positioning determines the cleavage plane during cell division and is critical for stem cell 
function and tissue formation. In somatic animal cells, spindle assembly is strongly 
influenced by centrosomes. At the G2 to M transition, these organelles undergo a 
maturation process that enhances the recruitment of γ-tubulin ring complexes (γTuRCs) 
and other MT regulatory factors. Concomitantly, the two centrosomes separate from 
each other to form the spindle poles. These crucial events are controlled by three highly 
conserved serine/threonine kinases, Cdk1, Plk1 and Aurora A (Barr et al., 2004; 
Blagden and Glover, 2003; Nigg, 2001; Vagnarelli and Earnshaw, 2004). Cdk1 is initially 
activated at the centrosome (Jackman et al., 2003) and required for centrosome 
separation (Blangy et al., 1995; Sawin and Mitchison, 1995). Likewise, Plk1 and Aurora 
A localize to centrosomes and are activated at the G2/M transition, but the coordination 
of their activities is not presently understood. 
Plk1 and Aurora A are required for centrosome maturation and 
spindle assembly 
  When Plk1 activity is impaired by antibody injection (Lane and Nigg, 1996), 
RNAi-mediated Plk1 depletion (Hanisch et al., 2006; Sumara et al., 2004; van Vugt et 
al., 2004) or small molecule inhibitors (Lenart et al., 2007; McInnes et al., 2006; Peters 
et al., 2006), cells fail to recruit γ-TuRCs and often form monoastral spindles. Several 
candidate substrates of Plk1 have been identified, including abnormal spindle (asp) in 
Drosophila (do Carmo Avides et al., 2001) and translationally controlled tumor protein 
(TCTP) (Yarm, 2002), ninein-like protein (Nlp) (Casenghi et al., 2003) and Kizuna (Kiz) 
in vertebrates (Oshimori et al., 2006), but the exact role of Plk1 in spindle assembly 
remains unclear. 
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  Interestingly, RNAi-mediated depletion of Aurora A also results in the formation 
of monopolar spindles, decreased accumulation of γ-tubulin and reduced density of 
centrosomal MTs (Ducat and Zheng, 2004). Aurora A is thought to regulate MT 
nucleation and spindle pole formation through the recruitment of centrosomal proteins, 
including transforming acidic coiled-coil protein (D-TACC) (Giet et al., 2002), 
minispindles (Msps) (Barros et al., 2005) and centrosomin (CNN) in Drosophila (Berdnik 
and Knoblich, 2002), and the Msps homologue XMAP215 in Xenopus (Kinoshita et al., 
2005; Peset et al., 2005). Considering that both Plk1 and Aurora A play important roles 
in centrosome maturation and bipolar spindle formation, one would expect that the 
functions of these kinases should be coordinated. No direct interaction between the two 
kinases has yet been observed, but, interestingly, Plk1 is required for centrosomal 
localization of Aurora A (De Luca et al., 2006; Hanisch et al., 2006). 
Regulation of Plk1 and Aurora A  
Plk1 and Aurora A are activated through phosphorylation within their respective 
activation loops (T210 in human Plk1; T288 in human Aurora A (Jang et al., 2002; 
Littlepage et al., 2002), and both kinases are also controlled by additional mechanisms. 
In the case of Plk1, the C-terminal end domain (the so-called polo-box domain; PBD) 
functions as a phospho-peptide binding module that mediates the binding of Plk1 to 
proteins pre-phosphorylated by ‘priming’ kinases (Cheng et al., 2003; Elia et al., 2003a; 
Elia et al., 2003b). In the case of Aurora A, regulation appears to be conferred primarily 
through interactions with binding partners. Of several Aurora A interactors (Chen et al., 
2002; Farruggio et al., 1999; Hirota et al., 2003; Mori et al., 2007; Ouchi et al., 2004), 
the role of the MT binding protein TPX2 (Targeting Protein for XKlp2) is understood best 
(Eyers et al., 2003; Kufer et al., 2003; Tsai et al., 2003). Binding of the N-terminus of 
TPX2 triggers kinase activation through a conformational change that protects the 
activation loop of Aurora A from dephosphorylation by protein phosphatase 1(PP1) 
(Bayliss et al., 2003; Eyers et al., 2003). Moreover, TPX2 targets Aurora A to the mitotic 
spindle (Kufer et al., 2002) and confers regulation by the Ran GTPase spindle assembly 
pathway (Tsai et al., 2003).  
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Bora is a novel Aurora A interactor and activator 
Bora was recently identified as a novel binding partner of Aurora A (Hutterer et 
al., 2006). Its overexpression suppressed the centrosome maturation and asymmetric 
division defects of Drosophila Aurora A mutants. Furthermore, Bora was able to activate 
Aurora A, albeit to a modest extent. Activation of Cdk1 at the onset of mitosis triggered 
the translocation of Drosophila Bora from the nucleus to the cytoplasm, providing an 
attractive mechanism for the activation of cytoplasmic Aurora A. Finally, initial studies 
on human Bora (hBora) suggested an evolutionarily conserved function for this protein 
(Hutterer et al., 2006). In the following, we investigate the significance of the reported 
interaction between Aurora A and hBora (Hutterer et al., 2006). The results shown in the 
following chapter lead us to present a working model according to which Plk1 influences 
Aurora A function and localization through the regulation of the abundance of hBora. 
We emphasize that the proposed model will require further experimental testing and, for 
the time being, must be considered tentative. 
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Results II 
1. hBora, a novel Aurora A binding partner links Plk1 functions with 
Aurora A 
1.1 hBora interacts with Aurora A 
To confirm the reported interaction between Aurora A and hBora (Hutterer et al., 2006), 
these two proteins were overexpressed in HEK293T cells and co-immunoprecipitation 
experiments were carried out in either direction. The binding between Aurora A and 
hBora could be readily detected (Fig. 22). Interestingly, Aurora A bound preferentially to 
the phosphorylated (upshifted) form of hBora (Fig. 22A). Moreover, little if any binding 
could be seen between hBora and a catalytically inactive Aurora A mutant (Fig. 22A). 
These observations suggest that only the mitotically phosphorylated hBora interacts 
with active Aurora A. Using similar co-immunoprecipitation experiments, the Aurora A 
binding site could be mapped to the phosphorylated N-terminal domain (1-327) of 
hBora, while the C-terminal domain (329-559) failed to bind (Fig. 22B). To examine the 
ability of hBora to activate Aurora A, recombinant proteins were mixed in vitro and 
Aurora A activity was assayed through autophosphorylation as well as phosphorylation 
of an exogenous substrate, myelin basic protein (Fig. 22C). Activation of Aurora A could 
be detected, but when compared to TPX2 (Eyers et al., 2003), the stimulatory effect of 
hBora appeared to be modest, in agreement with previous data (Hutterer et al., 2005). 
This prompts the question of whether the activation of Aurora A is the main 
physiological function of hBora.   





Figure 22. hBora interacts with Aurora A. 
(A) HEK293T cells were co-transfected with plasmids expressing myc-hBora, FLAG-Aurora A wild type, 
kinase dead (KD) or FLAG-Mst2 (negative control) for 48 h and arrested by nocodazole. FLAG-
immunoprecipitates were immunoblotted with antibodies against FLAG and myc. Note that the upshifted 
form of hBora co-immunoprecipitates preferentially with wild type Aurora A. (B) HEK293 cells were 
transfected with plasmids expressing myc-tagged hBora, hBoraN and hBoraC and arrested by 
nocodazole. Aurora A-immunoprecipitates were immunoblotted with antibodies against Aurora A and 
myc. Single asterisk (*) denotes unphosphorylated hBora and doube asterisk (**) indicates 
phosphorylated hBora. Note preferential binding of the phosphorylated, upshifted hBora N-terminus. (C) 
In vitro kinase assay was performed using His-Aurora A treated with PP1 with an increasing amount of 
MBP-hBora or MBP-TPX2 aa1-43 (MBP-TPX2N). Kinase reactions were performed for 30 min at 30 °C 
in the presence of [γ-32P]ATP, using myelin basic protein (MBP) as a substrate. Phosphate 
incorporation was visualized by autoradiography and a Western blot demonstrates the presence of 
equal amounts of Aurora A in all samples. 
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1.2 Cell cycle expression of hBora 
To study the cell-cycle regulation of hBora, HeLaS3 cells were arrested at G1/S 
(thymidine block) or prometaphase (nocodazole) and analyzed at different time points 
after release (Fig. 23A and B, respectively). As demonstrated using a specific polyclonal 
antibody raised against the full-length protein, hBora levels were maximal at 8 h after 
release from the thymidine block (Fig. 23A, t=8) and in nocodazole-arrested cells (Fig. 
23B, t=0). This peak expression coincided with maximal expression of cyclin B1 and 
was accompanied by a retarded electrophoretic mobility (upshift), suggesting that hBora 
was modified during mitosis. The hBora upshift was also observed in mitotic cells that 
had been collected by shake off without any use of drugs, indicating that it is not a drug-
induced artefact (Fig. 23B, shake off). Upon release from the nocodazole block, hBora 
levels gradually decreased (Fig. 23B, t=80 and t=100) before the protein reaccumulated 
in a faster migrating form at later times (Fig. 23B, t=140, 160). As shown in Figure 23C, 
the expression of myc-tagged hBora in HEK293T cells also resulted in the appearance 
of an upshifted band in nocodazole but not aphidicolin arrested cells, and this upshifted 
band was sensitive to phosphatase treatment, indicating that it reflects a 
phosphorylated form of hBora (see also Fig. 28A). Together, these data indicate that 
hBora is maximally expressed during early mitosis, similar to Aurora A and cyclin B1 
(Fig. 23B), and, moreover, that hBora is phosphorylated on specific sites during early 
mitotic progression.  
The phosphorylation of hBora is likely to be complex, as several candidate 
mitotic kinases act on hBora, at least in vitro ((Hutterer et al., 2006), Fig. 24A). In 
particular, hBora could be phosphorylated by Cdk1/cyclin B, Plk1 and Aurora A but not 
Aurora B, and both Cdk1/cyclin B and Plk1 retarded the electrophoretic mobility of this 


































Figure 23. hBora is cell-cycle regulated and phosphorylated during mitosis. 
(A) HeLaS3 cells were released from a G1/S arrest (induced by double thymidine block), samples were 
collected at the indicated times (hours) and probed by Western blotting, using the antibodies indicated. 
Cyclin B levels indicate exit from mitosis and α-tubulin levels serve as a loading control. The first lane 
contains a lysate prepared from an asynchronous culture (Asyn). (B) HeLaS3 cells were released from 
nocodazole-induced mitotic arrest (indicated as time 0), samples were collected every 20 min and probed 
by Western blotting, using the antibodies indicated. The electrophoretic mobility of myc-hBora 
overexpressed in HEK293T cells was assayed by Western blotting performed on interphase (aphi, 
aphidicolin-arrested) or mitotic (noc, nocodazole-arrested) lysates. Myc-hBora from mitotically arrested 
cells was immunoprecipitated and treated for 30 min with or without alkaline phosphatase (AP). 
 








1.3 Identification of multiple phosphorylation sites in hBora 
The above results show that hBora gets highly phosphorylated during mitosis and can 
be phosphorylated by Cdk1, Plk1 and Aurora A in vitro. Together with Dr. Xiuling Li, we 
next tried to identify hBora phosphorylation sites from two different sources: first we 
analyzed GST-tagged hBora purified from Sf9 insect cells treated with or without 
okadaic acid (OA), and second, we studied MBP-tagged hBora purified from bacteria, 
after phosphorylation by Cdk1, Plk1 and Aurora A in vitro. Samples were separated by 
SDS-PAGE. Then, gel bands were excised and tryptic digestion was performed. For 
identification of phosphorylation sites within these tryptic digests (Shevchenko et al., 
1996b), phosphorylated peptides were first identified by MALDI-TOF mass spectrometry 
(Brucker Daltonik, Bremen, Germany) and subsequently confirmed by post source 
decay (PSD) (Hoffmann et al., 1999a). The exact localization of the phosphorylated 
residues within the peptides was determined by MS-MS based sequencing using a 
quadrupole time-of-flight (QTOF) mass spectrometer (Table 2). These results indicate 
Figure 24. hBora is phosphorylated 
by Cdk1, Plk1 and Aurora A but not 
Aurora B in vitro. 
(A) In vitro kinase assay were 
performed with Cdk1, Aurora A, 
Aurora B or Plk1 and MBP-hBora as a 
substrate in the presence of [γ-
32P]ATP and the samples were 
subjected to SDS-PAGE. Coomassie 
blue (CBB) staining shows protein 
loading. (B) Plk1 and Cdk1 
phosphorylations lead to upshifts of 
hBora. Experiments were performed 
as in A, but samples were subjected to 
7.5% SDS-PAGE to better reveal 
hBora upshifts upon phosphorylation. 
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that hBora can be phosphorylated at many different sites. The significance of one of the 
sites identified here (S252) will be addressed below. 
Table 2. Summary of the phosphorylation sites identified in hBora phosphorylated by Cdk1, Plk1 and 
Aurora A in vitro and in hBora purified Sf9 insect cells treated with or without okadaic acid (OA). The 
phosphorylated residues are indicated in red. 
No. Site Peptide 
Sf9 w.o. 
OA 







1 T12 MQIpTPETPGR X X    
2 T15 MQITPEpTPGR  X X   
3 S47 (VFK) pSTKLPTPGK     X 
4 T52 STKLPpTPGK  X X   
5 S59 WpSIDQLAVINPVEIDPEDIHR  X    
6 Y82 QALpYLSHSR     X 
7 S84 QALYLpSHSR  X    
8 S112 DVIVPpSPWTDHEGK  X X   
9 T131 CpTNINSDSPVGK     X 
10 S137 CTNINSDpSPVGK  X X   
11 T144 KLpTIHSEK     X 
12 S183 ADEFADQpSPGNLSSSSLR X X X   
13 S188 ADEFADQSPGNLpSSSSLRR  X X  X 
14 S189 ADEFADQSPGNLSpSSSLRR  X    
15 S191 ADEFADQSPGNLSSSpSLR X X    
16 S239 pSPLQTPSSGQFSSSPIQApSAK X  X   
17 T243 SPLQpTPSSGQFSSSPIQASAK     X 
18 S246 SPLQTPSpSGQFSSSPIQASAK     X 
19 S250 SPLQTPSSGQFpSSSPIQASAK  X X   
20 S252 SPLQTPSSGQFSSpSPIQASAK X X X   
21 S257 SPLQTPSSGQFSSSPIQApSAK   X   
22 T287 KYSLGSITSPSPISSPTFSPIEFQIGEpTPLSEQR    X  
23 T296 KFpTVHSPDASSGTNSNGITNPCIR     X 
24 T299 FTVHpSPDASSGTNSNGITNPCIR X X X   
25 T312 KFTVHSPDASSGTNSNGIpTNPCIR     X 
26 S318 (CIR)pSPYIDGCSPIK  X X   
27 S325 SPYIDGCpSPIK  X X   
28 S331 NWpSPMR  X X   
29 S339 LQMYpSGGTQYR   X  X 
30 T342 LQMYSGGpTQYR   X   
31 S389 QFpSNEASTHGTHLVVTAMSVTQNQSSASEK X X    
32 T432 EKDNNpTVDMVDPIEIADETTWIK  X    
33 S552 TApSPFQCSpSP  X X   
34 S558 TASPFQCSpSP  X X   
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1.4 Depletion of hBora causes aberrant spindle formation 
To explore the consequences of hBora depletion, two siRNA duplexes targeting hBora 
were used. Western blots performed on mitotic cells revealed extensive depletion of 
hBora after 72h of siRNA treatment, whereas levels of Aurora A and Plk1 remained 
unchanged (Fig. 25A). Compared to a GL2 control duplex (Elbashir et al., 2001), the 
two hBora siRNA duplexes produced similar increases in mitotic indices (Fig. 25B) and 
qualitatively similar spindle abnormalities (Fig. 26A). In response to hBora depletion, 
many cells displayed bipolar spindles that were larger and denser than normal spindles 
(Fig. 26B). In addition, we observed cells with long, wavy spindles and lagging 
chromosomes and, as reported previously (Hutterer et al., 2006), occasional multipolar 
spindles (Fig. 26B). Long, wavy spindles occasionally displayed fragmented poles (not 
shown), suggesting that they evolved to form multipolar spindles, a conclusion 





Figure 25. hBora depletion leads to an increase in mitotic indices. 
(A) Effective depletion of hBora from nocodazole arrested HeLaS3 cells arrested by 72h siRNA treatment 
is shown by Western blotting. Note that Plk1 and Aurora A levels are unaffected.-tubulin levels provide a 
loading control. (B) Histogram summarizing the mitotic indices of cells treated with GL2 or hBora siRNA 
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Since hBora is a binding partner of Aurora A, we next asked whether hBora 
depletion would affect Aurora A localization. To facilitate comparisons with controls, we 
focused on those hBora-depleted cells that showed relatively normal bipolar spindles. 
Even though such cells may not reflect the most severe phenotype of hBora depletion, 
immunofluorescence microscopy readily revealed an enrichment of Aurora A on the 
spindles (Fig. 26C). In addition, the density of spindle MT was increased in hBora-
depleted cells (Fig. 26C), whereas other proteins, notably pericentrin or Plk1, were not 
detectably affected (not shown) 
 To determine whether the increase in MT density in the spindles of hBora-
depleted cells was due to an increased stability of kinetochore MTs (K-fibers), cells 
were subjected to cold treatment (Rieder and Borisy, 1981). After 1h of cold treatment, 
only centrosomal tubulin remained visible in control cells, as expected. In stark contrast, 
K-fibers remained largely intact in hBora-depleted cells (Fig. 26D), regardless of which 
hBora duplex was used for depletion (Fig. 26E). Taken together, the above results 
indicate that hBora depletion results in the increased association of Aurora A with the 
spindle apparatus and concomitant stabilization of K-fibers. This then presumably leads 
to the formation of dense or aberrantly shaped (long and wavy) spindles, followed by 




































Figure 26. Aberrant spindle formation in hBora-depleted cells. 
(A) Histogram illustrating percentages of mitotic cells with spindle abnormalities. HeLaS3 cells treated 
with GL2 or hBora siRNA duplexes for 72h and released from double thymidine block were fixed after 10h 
and stained with α-tubulin and DAPI for determining spindle morphology. Results are from 3 individual 
experiments (300-350 cells each), and bars indicate standard deviations. (B) HeLaS3 cells were treated 
with siRNA duplex specific for hBora or GL2 control for 72h. Aurora A and α-tubulin were visualized by 
immunofluorescence. Bar, 10μm. (C) HeLaS3 cells were treated as in (A) and stained for indicated 
proteins. Note increased microtubule density and increased Aurora A staining on the spindles of hBora-
depleted cells. Bar, 10μm.  HeLaS3 cells treated as in (A) were placed on ice for 1h and the presence of 
cold stable microtubules (green) was assessed by immunofluorescence. Bar, 10μm. (E) Histogram 
summarizing percentages of mitotic cells with cold-stable K-fibers. Results are from three independent 
experiments (n=100-150); bars indicate standard deviations. 
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1.5 Excess hBora causes Aurora A mislocalization and monoastral spindle 
formation 
Staining of mitotic HeLaS3 cells with anti-hBora antibodies failed to highlight any 
specific structures (not shown) and immunostaining of ectopically expressed myc-
tagged hBora confirmed a diffuse localization of hBora (Fig. 27A). Remarkably, nearly 
all mitotic cells overexpressing hBora showed monoastral spindles (Fig. 27A), indicating 
that excess hBora interferes with bipolar spindle formation. The same phenotype was 
also observed upon overexpression of the N-terminus of hBoraN, whereas the hBoraC 
produced no effect (Fig. 27A). This strongly suggested that the induction of monoastral 
spindles by excess hBora reflected interference with Aurora A function. Indeed, 
overexpression of either hBora or hBoraN resulted in displacement of Aurora A from the 
spindle, whereas the kinase localized normally to the bipolar spindles of untransfected 
cells or cells expressing hBoraC (Fig. 27B).  Since the Aurora A binding site was 
mapped to the N-terminus of hBora ((Hutterer et al., 2006) Fig. 22B and Fig. 28A), the 
most straightforward interpretation of the above results is that excess cytoplasmic hBora 
interferes with bipolar spindle formation through the sequestration of Aurora A away 
from the spindle.  
 
Figure 27. Overexpression of hBora leads to monoastral spindle formation and Aurora A 
mislocalization. 
(A, B) HeLaS3 cells transfected with the indicated myc-tagged hBora constructs were fixed and stained 
with 9E10 anti-myc (red) and α-tubulin (green) (A) or with 9E10 anti-myc (green) and Aurora A (red) 
antibodies (B). DNA was stained with DAPI (blue). Bars, 10μm. 
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To corroborate the above conclusion, we generated a tetracycline (tet)-inducible 
HEK293 cell line that allows the controlled expression of myc-tagged hBoraN. As shown 
by Western blotting, tet-induction of hBoraN for 48h resulted in two myc-immunoreactive 
bands (Fig. 28A). The upper band was sensitive to alkaline phosphatase treatment, 
confirming that it represents a phosphorylated form of myc-hBoraN (Fig. 28A). 
Strikingly, more than 80% of the cells expressing hBoraN were arrested in mitosis and 
mostly displayed monoastral spindles (Fig. 28A) and, as seen before (Fig. 27A, B), 
Aurora A was displaced from these spindles (Fig. 28C). This was most obvious in 
comparison to the Aurora A localization in cells in which monopolar spindles were 
formed due to inhibition of the kinesin-related motor Eg5 by monastrol (Mayer et al., 
1999) (Fig. 28C, upper 
row). Upon induction of 
hBoraN, the recruitment 
of γ-tubulin was also 
drastically impaired, 
demonstrating a defect 
in centrosome 
maturation, whereas 
TPX2 and Aurora B 
analyzed for control 
were not displaced (Fig. 
28C).  
 
Figure 28. Tetracyclin-inducible myc-hBoraN 293 stable cell line. 
(A) Expression of myc-hBoraN in a stably transfected HEK293T cell line induced for 48h with tetracyclin 
(+tet) was analyzed by Western blotting with anti-hBora antibodies and anti-Aurora A antibodies, α-tubulin 
was used as loading control. Myc-hBoraN from induced cells was immunoprecipitated and treated with 
alkaline phosphatase (AP) in the presence or absence of phosphatase inhibitors (PI). Note the absence 
of the upper band in the sample treated with AP. The asterisk denotes the IgG heavy chain. (B) Cells 
induced as in (B) were fixed and stained with 9E10 anti-myc (red) and α-tubulin (green) antibodies. DNA 
was stained with DAPI (blue). Bar, 10μm. (C) Myc-hBoraN stable cell line was induced with tetracycline 
(+tet) for 48h or treated with 150μM monastrol (-tet, +MA) for control. The localization of indicated 
proteins was monitored by immunofluorescence. Bar, 10μm. 
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1.6 hBora interacts with Plk1 during mitosis  
We were intrigued by the remarkable similarity between the phenotype induced by 
excess hBora and that displayed by cells that lack Plk1 protein or activity, notably with 
regard to Aurora A recruitment to the centrosome (De Luca et al., 2006; Hanisch et al., 
2006). This prompted us to explore a potential link between hBora and Plk1. First, we 
asked whether hBora overexpression would perturb Plk1 localization. Indeed, induction 
of myc-hBoraN led to Plk1 displacement from both the spindle poles and the 
kinetochores (Fig. 29A) and, as described above for Aurora A, this effect was induced 
by hBora and hBoraN, but not hBoraC (Fig. 29B). Next, we asked whether Plk1 and 
hBora might interact with each other in vivo. When myc-hBoraN was 
immunoprecipitated from the tet-inducible cell line, both Plk1 and Aurora A could readily 
be detected in the immunoprecipitates, whereas TPX2 and Aurora B were absent (Fig. 
30A). These results are in agreement with the data shown in Figure 3E and, 






Figure 29. Overexpression of hBora 
displaces Plk1 from the centrosomes 
and kinetochores. 
(A) Myc-hBoraN stable cell line was 
induced with tetracycline (+tet) for 48h 
or treated with monastrol (-tet, +MA) for 
control. Plk1 was visualized by 
immunofluorescence. Bar, 10μm. (B) 
HeLaS3 cells transfected with myc-
tagged hBora, hBoraN and hBoraC
were fixed and stained with 9E10 anti-
myc (green) and Plk1 (red) antibodies. 
DNA was stained with DAPI (blue). Bar, 
10μm. 
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To determine which domain of Plk1 interacts with hBora, HEK293T cells were co-
transfected with myc-hBora and various GFP-Plk1 constructs and co-
immunoprecipitation experiments were then performed on nocodazole-arrested cells. As 
shown in Figure 30B, phosphorylated forms of hBora were co-precipitated with both 
wild-type (WT) and catalytically inactive (KD) versions of Plk1, indicating that Plk1 
activity is not required for this interaction. However, the hBora proteins co-precipiated by 
active and inactive versions of Plk1 displayed different electrophoretic mobilities, 
suggesting that they differed in phosphorylation state. Most importantly, the GFP-tagged 
C-terminal end domain of Plk1 (GFP-Plk1PBD) also bound to hBora, whereas the 
catalytic domain  (GFP-Plk1Cat) did not (Fig. 30B). Taken together, the above results 
suggested that Plk1 interacts via its PBD with a phosphorylated form of hBora and that 
this binding prompts hBora phosphorylation by Plk1. Both Drosophila and human Bora 
can be phosphorylated by Cdk1 ((Hutterer et al., 2006); Fig. 24). Moreover, we could 
identify one potential Cdk1-induced PBD-docking site in hBora (S252), which has been 
conserved in evolution (Fig. 30C). Thus, we tested the functionality of this candidate 
PBD docking site in a Far-Western ligand binding assay (Neef et al., 2003). Without pre-
phosphorylation by Cdk1, wild-type hBora showed very little binding to the GST-PBD, 
but strong binding was seen after phosphorylation (Fig. 30D, central panel). PBD 
binding to a S252A mutant of hBora was markedly reduced, albeit not completely 
abolished, even after pre-phosphorylation by Cdk1 (Fig. 30D, central panel). Virtually no 
binding to any hBora protein was seen with a PBD mutant (GST-PBD AA) that is unable 
to bind to phosphopeptides (Elia et al., 2003a) (Fig. 30D, right panel), and Coomassie 
Blue staining confirmed the presence of equal amounts of hBora (Fig. 30D, left panel). 
These results identify the motif centred on S252 as a major Cdk1-dependent Plk1-PBD 











Figure 30. hBoraS252 is a PBD docking site. 
(A) Myc-hBoraN was immunoprecipitated with 9E10 anti-myc antibody from nocodazole arrested cells 
treated with or without tetracycline (tet) for 48h. Immunoprecipitates were probed by Western blotting with 
antibodies against the indicated proteins. The asterisk denotes the IgG heavy chain. (B) Myc-hBora and 
GFP tagged-Plk1 constructs [wild-type (WT), kinase dead (KD), catalytic domain (Cat), polo-box domain 
(PBD)] were co-expressed in HEK293T cells for 48h and cells were arrested with nocodazole for the last 
16h. The presence of myc-hBora in GFP-immunoprecipitates was assessed by Western blotting. (C) 
Evolutionary conservation of the putative PBD binding site in hBora (underlined). The phosphorylated 
serine is marked in red. Numbers refer to their position. (D) In vitro kinase assay were performed with 
Cdk1-cyclin B (or buffer for control) and the indicated proteins as substrates. The samples were subjected 
to SDS-PAGE and subsequently a Far Western ligand blotting assay using GST-PBD and GST-PBD-AA 
was performed. Coomassie blue staining (CBB) showed protein loading.  
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1.7 Plk1 triggers the SCFβ-TrCP mediated degradation of hBora 
Having shown that hBora is a binding partner (Fig. 22) and potential substrate of Plk1 
(Fig. 24), we next explored the physiological significance of this interaction. We 
discovered that siRNA-mediated depletion of Plk1 led to the accumulation of hBora to 
very high levels, as compared to control or TPX2-depleted cells (Fig. 32A). This 
suggested that Plk1 might be required for regulating hBora stability, similar to the 
recently established role of this kinase in triggering the degradation of other regulators 
of cell cycle progression, notably Wee1 (Watanabe et al., 2004), Claspin (Mamely et al., 
2006), Emi1 (Moshe et al., 2004) and Erp1/Emi2 (Liu and Maller, 2005; Rauh et al., 
2005; Tung et al., 2005). This Plk1-dependent mechanism for regulated protein 
degradation requires the phosphorylation of a conserved motif (DpSGxxpT), a so-called 
phosphodegron, which then triggers the binding of the β-transducin repeat-containing 
protein (β-TrCP) component of a Skp1–Cul1–F-box-protein (SCF) ubiquitin ligase, 
followed by polyubiquitination and proteasomal degradation. Examination of the hBora 
sequence revealed a potential β-TrCP binding motif within the C-terminus, which is 
conserved amongst species (Fig. 32B). To explore the hypothesis that Plk1 might act 
through this putative phosphodegron, we first tested the ability of Plk1 to phosphorylate 
various recombinant hBora proteins in vitro. Plk1 readily phosphorylated full-length 
hBora, as well as N- and C-terminal fragments, but phosphorylation was reduced upon 
mutation of the putative phospho-degron (S497A/T501A) (Fig. 31). Next, we depleted 
Plk1 from HeLa cell lines moderately expressing either full-length hBora or hBoraN and 
then examined hBora proteins levels in lysates prepared from nocodazole-arrested 
cells. Similar to the results described above for endogenous hBora (Fig. 32A), Plk1 
depletion led to an accumulation of myc-hBora (Fig. 32C). In stark contrast, hBoraN 
accumulated to similar levels in both control and Plk1-depleted cells (Fig. 32C), strongly 
supporting the hypothesis that the Plk1-dependent degradation of hBora is mediated by 
a phosphodegron within the C-terminal domain.  






To further corroborate the involvement of Plk1 activity in hBora degradation, we 
tested the ability of catalytically inactive Plk1 (KD) to interfere with hBora degradation by 
acting as a dominant negative mutant. In response to co-expression of full-length myc-
hBora with Plk1KD, a significant increase in hBora (phospho-) protein levels could be 
seen, whereas the co-expression of wild-type Plk1 (WT) had no obvious effect (Fig. 
32D). Mutation of the phosphodegron (S497/T501) or the PBD-docking site (S252A) 
both abolished responsiveness of the mutant hBora proteins to alterations in Plk1 
activity (Fig. 32D). Finally, the mitotically phosphorylated form of wild-type hBora could 
readily be co-immunoprecipitated with β-TrCP, whereas both the phosphodegron and 
the PBD-docking site mutants failed to interact (Fig. 32E). Taken together, these results 
demonstrate that the phosphodegron identified in hBora is functional and that Plk1 
binding is essential for triggering the β-TrCP-mediated degradation of hBora. As a 





Figure 31. Plk1 phosphorylates the conserved 
phosphodegron of hBora in vitro. 
Bacterially expressed MBP-tagged hBora, hBoraN, 
hBoraC and hBoraC S497A/T501A) were incubated 
together with Plk1 isolated from baculovirus in the 
presence of [γ-32P]ATP in vitro. Kinase reactions were 
analysed by SDS–PAGE followed by autoradiography. 
 
 




Figure 32. Mitotic degradation of hBora depends on Plk1 and β-TrCP. 
(A) HeLaS3 cells were treated with siRNA duplexes specific for Plk1 for 36h or for TPX2 (or GL2 for 
control) for 72h. Cells were treated with nocodazole for the last 16h and collected by shake off. Cell 
extracts were probed by Western blotting with antibodies against the indicated proteins. α-tubulin levels 
provide a loading control. (B) Evolutionary conservation of the putative phosphodegron in hBora 
(underlined). The phosphorylated serine and threonine are marked in red. Numbers refer to their position.  
Note that the mouse sequence shows a slight deviation from the proposed consensus sequence 
(DpSGxxpT). (C) Expression of myc-hBora full-length or hBoraN in stable HeLaS3 cell lines was induced 
for 12h with tetracyclin before  Plk1 and GL2 siRNA duplexes were added for another 36h. Cells were 
treated with nocodazole for the last 16h and were then collected by shake-off. Cell extracts were probed 
by Western blotting with antibodies against the indicated proteins and equal loading is shown by probing 
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for α-tubulin. (D) HEK293T cells were co-transfected with various constructs of myc-hBora (wild-type, 
phosphodegron mutant; S497A/T501A, and PBD docking mutant; S252A) and myc-Plk1 WT or KD for 
48h. Cell extracts were probed by Western blotting with antibodies against the indicated proteins and α-
tubulin levels provide a loading control. The expression between different hBora constructs is not 
comparable, because of variations in transfection efficiencies. Various constructs of myc-hBora (as in D) 
and FLAG-β-TrCP1 were coexpressed in HEK293T cells for 48h and treated with nocodazole for the last 
16h. FLAG-immunoprecipitates were analyzed by immunoblotting with myc and FLAG antibodies. (E) 
Various constructs of myc-hBora (as in E) and FLAG-β-TrCP1 were coexpressed in HEK293T cells for 
48h and treated with nocodazole for the last 16h. FLAG-immunoprecipitates were analyzed by 
immunoblotting with myc and FLAG antibodies.  
1.8 Plk1 regulates Aurora A by controlling hBora levels  
Considering that hBora acts as a regulator of Aurora A, but is itself controlled by Plk1, it 
follows that hBora could contribute to coordinate the functions of these two key 
regulators of mitotic progression. One specific prediction from our data is that Plk1 may 
determine Aurora A localization and activity through its ability to regulate the 
intracellular levels of hBora. Indeed, when Aurora A was immunoprecipitated from Plk1-
depleted cells, most Aurora A was complexed to hBora, reflecting the increased levels 
of hBora in such cells (Fig. 33). Importantly, the amounts of TPX2 that could be co-
precipitated with Aurora A were substantially reduced, although the total cellular level of 
TPX2 was not changed (Fig. 33). This indicates that hBora competes with TPX2 for 
Aurora A binding and that levels of hBora determine how much Aurora A is available for 
binding to other partners, notably TPX2.  
 
 
Figure 33. hBora competes with TPX2 in cells. 
HeLaS3 cells were treated with Plk1 or GL2 siRNA duplexes for 36h. 
Cells were treated with nocodazole for 16h before harvesting them 
by shake-off.  Cell extracts and Aurora A immunoprecipitates were 
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The above findings also suggested an attractive explanation for the observation that 
Plk1 is required for Aurora A localization to spindle poles (De Luca et al., 2006; Hanisch 
et al., 2006). Specifically, we reasoned that the requirement for Plk1 during centrosome 
maturation and spindle formation could reflect, at least in part, its role in lowering hBora 
levels below a threshold, such as to allow Aurora A to exert its functions on the 
centrosome and spindle. This model predicted that a reduction of hBora levels might 
alleviate at least some of the early mitotic defects that are typically seen in Plk1-
depleted cells. To explore this possibility, we treated cells with siRNA duplexes targeting 
Plk1 and hBora, either in combination or singly (paired with GL2 for control), and asked 
whether co-depletion of hBora and Plk1 would bring Aurora A back to the centrosome 
and restore spindle bipolarity. Co-depletion of hBora with Plk1 suppressed the 
accumulation of hBora that normally results from Plk1 depletion, as expected (Fig. 34A).  
Both Plk1 depletion and Plk1/hBora co-depletion led to marked increases in mitotic 
indices (Fig. 34B), indicating that not all early mitotic functions of Plk1 can be attributed 
to its interaction with hBora, but the two cell populations displayed remarkably different 
phenotypes. Whereas the Plk1-depleted cells displayed mostly monopolar spindles, as 
expected, the Plk/hBora co-depleted cells showed mostly bipolar spindles, albeit with 
uncongressed chromosomes (Fig. 34C and D). Moreover, Aurora A was displaced from 
spindle poles in Plk1-depleted cells, consistent with previous data (De Luca et al., 2006; 
Hanisch et al., 2006), but largely restored to these structures in Plk1/hBora co-depleted 
cells (Fig. 34E lower panel). To facilitate the comparison with Plk1-depleted cells, 
Plk1/hBora co-depleted cells were also treated with monastrol to induce monopolar 
spindles (Fig. 34E middle panel) and, furthermore, both cell populations were exposed 
to 4oC in order to depolymerize spindle MTs and better visualize centrosome-associated 
Aurora A (Fig. 34F). Taken together, these results demonstrate that co-depletion of 
hBora largely rescued the defects in bipolar spindle formation and Aurora A localization 
that normally result from Plk1 depletion.  




Figure 34. Plk1 regulates Aurora A localization by modulating hBora protein levels. 
(A) HeLaS3 cells were treated with different combination of siRNA duplexes and arrested by nocodazole. 
Lysates were then assayed by immunoblotting against the indicated proteins. Total amount of duplexes 
were held constant at 100nM.  (B) Histogram showing the mitotic indices of HeLaS3 cells treated with 
different siRNA duplexes. Results are from 3 individual experiments (300-350 cells each), and bars 
indicate standard deviations. (C) α-tubulin (green) and DAPI (blue) staining was performed on cells 
treated with combination of siRNA duplexes as indicated. Bar, 10μm. (D) Histogram summarizes the 
percentages of mitotic cells with monopolar/ bipolar spindle in experiments performed as in (B). Results 
are from 3 independent experiments (n=300-350), bars indicate standard deviations. (E) HeLaS3 cells 
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treated with Plk1/GL2 or Plk1/hBora siRNA duplexes and subsequently with or without 150μM monastrol 
(MA) were fixed and stained for Aurora A (red) and pericentrin (green).  Bar, 10μm. (F) Same as E, but 
cells were subjected to cold treatment for 90min before fixation and staining. 
 
2. Functional studies of Aurora A 
2.1 Aurora A depletion leads to long/multipolar spindle formation and abnormal 
centriole splitting 
In a final series of experiments, we have used siRNA to explore the function of Aurora 
A.  HeLaS3 cells were treated with GL2 or Aurora A siRNA duplexes for 72h and then 
were released from a double thymidine block for 12h to enrich for mitotic cells. While 
Western blotting showed an effective depletion 
of Aurora A protein (Fig. 35), IF microscopy 
showed weak residual staining of Aurora A at 
the centrosome for Aurora A siRNA treated 
cells (not shown). Aurora A depletion led to an 
increase in mitotic index when compared to 
controls (from 10% to 30%) and to massive 
apoptosis. In addition, Aurora A depletion 
caused severe spindle abnormalities during 
mitosis. More than 80% of mitotic cells formed 
either abnormally long or multipolar spindles, 
which were found in fewer than 10% of control 
cells (Fig. 36A and C). Pericentrin staining revealed centrosome abnormalities (Fig. 
36B). Aurora A depleted cells often had more than 2 centrosomes with irregular shape, 
indicating that the centrosome may fragment which then resulted in abnormal spindles 
with diffuse or multiple poles. To find out whether the formation of multipolar spindles is 
caused by centrosome overduplication, cells were stained with centrin antibodies to 
visualize centrioles (Fig. 36A and B). In control cells, each centrosome (as indicated by 
pericentrin staining) consists of a pair of centrioles (as indicated by centrin staining) 
(Fig. 37A). Aurora A depleted cells frequently carried two pairs of centrioles, indicating 
siRNA
GL2   AuroraA
α-tubulin
Aurora A
Figure 35. Depletion of Aurora A. 
Effective depletion of Aurora A after 
72h siRNA treatment is shown by 
Western blotting.  α-tubulin levels 
provide a loading control. 
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that the centrosome duplicated normally (Fig. 37). However, instead of centrioles being 
arranged pairwise, more than 60% of mitotic cells treated with the Aurora A siRNA 
duplexes showed split centrioles (Fig. 37). The above data showed that the multipolar 
spindles formed in Aurora A depleted cells may arise from abnormal centriole splitting 
which results in the formation of multiple microtubules organizing centres. Thus, we 
conclude that Aurora A is required for centriole cohesion in mitosis.  
  
 
Figure 36. Aurora A depletion leads 
to multipolar spindle formation. 
(A) HeLaS3 cells were treated with 
Aurora A siRNA duplexes for 72h and 
synchronized by double thymidine 
block. Cells were fixed and stained 
with α-tubulin (green) and Aurora A 
(red) antibodies. DNA was stained 
with DAPI (blue). Bar, 10μm. (B) 
Same as A, but cells were stained with 
pericentrin (green) and Aurora A (red) 
antibodies. Bar, 10μm. (C) Histogram 
summarizes percentage of mitotic 
cells with spindle abnormalities. 
Results from three independent 
experiments (n=100-150); bars 
indicate standard deviations. 
 




Figure 37. Aurora A depletion induces centriole splitting in mitosis. 
(A) Cells were treated as described in the legend to Fig. 36 and then stained with centrin (red) and 
pericentrin (green) antibodies to visualize different centrosome abnormalities. (B) Diagrams depict 
different types of centrosome abnormalities and centrioles shown in green. Cells containing 2 pairs of 
centrioles are defined as normal (1, 5). Cells with more than 2 pairs of centrioles reflect centrosome 
overduplication (2, 4) and cells with unpaired centrioles reflect premature splitting (3+4) (C) Quantitative 
studies demonstrate the percentages of mitotic cells showing centrosome overduplication (left histogram) 
or centriole splitting (right histogram). 
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2.2 Aurora A activity is required for centrosome separation 
We have shown above (section 1.5) that the mislocalization of both Plk1 and Aurora A 
in hBoraN overexpressing cells leads to monoastral spindle formation (Fig 27). To 
check whether we could rescue the centrosome separation defects by reintroducing 
Aurora A and whether the activity of Aurora A was required for such a rescue, we 
overexpressed wild-type (WT) or kinase dead (KD) version of Aurora A in hBoraN-
expressing HEK293 cell (Fig. 38). Both GFP-tagged Aurora A WT and KD localized 
normally to centrosomes and spindles in mitotic cells (Fig. 38). However, only 
overexpression of catalytically active Aurora A, but not kinase dead Aurora A, restored 
spindle bipolarity in hBoraN overexpressing cells. This indicates that Aurora A kinase 
activity is required for centrosome separation and the maintenance of spindle bipolarity. 
 
  
Figure 38. Overexpression of Aurora A WT but not KD restores bipolar spindle formation in 
hBoraN overexpressing cells. 
Myc-hBoraN stable cell line was induced with tetracycline (+tet) and transfected with GFP-Aurora A WT 
or GFP-Aurora A KD for 48h. Cells were fixed and stained with α-tubulin (red) and DAPI (blue) to 
visualize the spindle and DNA morphologies, respectively.  
2.3 Aurora A localization is required for centriole cohesion 
Overexpression of hBora leads to monoastral spindle formation due to the 
mislocalization of both Plk1 and Aurora A. To specifically test the influence of Aurora A 
mislocalization in cells, we overexpressed hBora1-232 in HEK293 cells. As shown by 
immunoprecipitation, this mutants bind only to Aurora A but not to Plk1 (Fig. 39A). By 
immunofluorescence, we could show that Aurora A is displaced upon overexpression in 
Myc-hBora1-232 cells. Interestingly, cells highly overexpressing Myc-hBora1-232 
formed mostly multipolar spindles (Fig. 39 upper and middle panel) with split centrioles 
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(Fig. 39B lower panel, note that the centrioles are disengaged when we used CAP350 
as a centriole marker). This confirms that Aurora A localization at the centrosome is 











Figure 39. Displacement of Aurora A leads to multipolar spindle formation and centriole splitting. 
(A) Myc-hBora or Myc-hBora1-232 and FLAG-Aurora A were overexpressed in HEK293T cells arrested 
by nocodazole. The presence of endogenous Plk1 and FLAG-Aurora A in the Myc-coimmunoprecipitates 
were detected by Western blotting. The asterisk denotes the IgG heavy chain. (B) Myc-hBora1-232 was 
overexpressed in HEK293T cells for 48h. Cells were fixed and stained with Myc (red) and DAPI (blue), 
together with Aurora A, α-tubulin (red) or CAP350.  




1. Plk1 controls the function of Aurora A kinase by regulating the 
protein levels of hBora 
We have studied the regulation and function of hBora, a recently described  
interactor of Aurora A (Hutterer et al., 2006). Our studies indicate that precise hBora 
levels are critical for correct Aurora A localization and spindle assembly. Furthermore, 
we demonstrate that hBora binds not only to Aurora A but also to Plk1. In particular, the 
phosphorylation of hBora on the Cdk1 site S252 triggers the recruitment of Plk1, which 
then phosphorylates hBora within a conserved phosphodegron motif, resulting in the 
SCFβ-TrCP- mediated degradation of hBora. In support of this scenario, interference with 
Plk1 activity results in a drastic upregulation of hBora and concomitant sequestration of 
Aurora A to the cytosol. Thus, by virtue of its ability to regulate the abundance of a 
cytoplasmic hBora-Aurora A complex, Plk1 controls the availability of Aurora A for 
interactions with spindle-associated partners such as TPX2. This mechanism also 
provides an attractive molecular explanation for recent data suggesting that Plk1 acts 
upstream of Aurora A in centrosome maturation and spindle assembly (De Luca et al., 
2006; Hanisch et al., 2006). Collectively, our findings lead us to propose that hBora 
contributes to integrate the functions of three major mitotic kinases, Cdk1, Plk1 and 
Aurora A. 
hBora levels are critical for proper spindle assembly 
In response to siRNA-mediated depletion of hBora, we observed the formation of 
long and wavy spindles, which eventually progressed to form multipolar spindles. In 
addition, we observed unusually ‘fat’ spindles that were characterized by increased MT 
density, increased amounts of spindle-associated Aurora A, and increased cold stability 
of K-fibers. The exact mechanisms underlying these spindle defects remain to be 
unraveled, but since hBora and TPX2 do not bind simultaneously to Aurora A, any 
reduction in hBora levels is expected to favor complex formation between Aurora A and 
spindle-associated activators such as TPX2 (Eyers et al., 2003; Kufer et al., 2002; Tsai 
et al., 2003). In turn, the increased abundance of Aurora A on the spindle is likely to 
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cause enhanced activity of downstream effectors, notably chTOG, the human homolog 
of Xenopus XMAP215 and Drosophila minispindles (Barros et al., 2005; Giet et al., 
2002; Kinoshita et al., 2005; Peset et al., 2005). Consistent with the above 
interpretation, the phenotypes seen in hBora-depleted cells resemble those of cells 
overexpressing Aurora A (Anand et al., 2003; Meraldi et al., 2002).  
hBora interacts not only with Aurora A but also with Plk1  
Striking spindle defects were also observed upon overexpression of hBora. 
Because excess hBora severely impaired the recruitment of both Aurora A and γ-tubulin 
to centrosomes, centrosome maturation and separation failed, resulting in the formation 
of monopolar spindles. Importantly, this phenotype was dependent on the ability of 
hBora to bind Aurora A. Excess hBora caused the sequestration of Aurora A into a 
diffusely localized pool, whereas TPX2 remained on the spindle apparatus, indicating 
that cytoplasmic hBora regulates the size of the Aurora A pool that is available for 
interactions with spindle-associated binding partners. In support of this conclusion, a 
rapid exchange of Aurora A between the spindle and the cytosol has previously been 
observed in photobleaching experiments (Stenoien et al., 2003). Considering that 
Aurora A displays activity when bound to hBora ((Hutterer et al., 2006), this study), it is 
entirely possible that this diffusely localized complex carries out important functions by 
acting on cytosolic substrates, perhaps regulating cell cycle progression. However, 
when hBora is deregulated, it perturbs Aurora A functions that are important for spindle 
assembly. Thus, the phenotypic consequences of hBora depletion and overexpression 
can largely be explained by deregulation of Aurora A complexes on mitotic structures. 
The monopolar spindles produced in response to hBora overexpression are 
remarkably similar to those seen in Plk1-depleted cells, in that both are characterized by 
a conspicuous absence of Aurora A from the unseparated centrosomes. This prompted 
us to explore a possible relationship between hBora and Plk1. We found that hBora 
interacts not only with Aurora A but also with Plk1, in both cases through its N-terminal 
domain. The interaction between hBora and Plk1 requires the Plk1 PBD and prior 
phosphorylation of hBora on a Cdk1 site, S252, in line with an increasingly well 
established model (Elia et al., 2003a). 
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Plk1 regulates hBora stability 
  Most importantly, we discovered that Plk1 depletion causes a massive 
upregulation of hBora, indicating that Plk1 normally sets a threshold for the abundance 
of hBora. Our study further revealed a mechanistic explanation for the control of hBora 
levels by Plk1. After its recruitment to hBora, Plk1 in fact phosphorylates a conserved 
phosphodegron, which then serves as a recognition motif for the ubiquitin ligase SCFβ-
TrCP, leading to the proteasomal degradation of hBora. At first glance, it may seem 
surprising that hBora levels peak during early mitosis, when both Cdk1 and Plk1 are 
active and thus would be expected to trigger hBora degradation. Interestingly, however, 
hBora is highly phosphorylated during early mitosis and appears to serve as a substrate 
for several mitotic kinases, including Aurora A. So, it is possible that the population of 
hBora that accumulates during early mitosis is protected against degradation through 
phosphorylation at particular sites and/or the binding of interaction partners (perhaps 
Aurora A itself). Furthermore, phosphatases counteracting Cdk1 and/or Plk1 are likely 
to contribute to the establishment of a steady-state level of hBora. Complex regulation 
of protein stability is not without precedent (Mailand et al., 2002) and so we anticipate 
the existence of multiple mechanisms to ensure physiological levels of hBora and 
appropriate timing of hBora degradation. As noted in the introduction, we emphasize 
that the proposed regulation of the hBora levels by the combined actin of Plk1 and β-
TrCP awaits confirmation through continued experimentation. We also note that hBora 
carries within its N-terminus potential destruction motifs for yet another ubiquitin ligase, 
the anaphase promoting complex/cyclosome (APC/C). So, although our data point to 
SCFβ-TrCP as the ubiquitin ligase responsible for Plk1-induced hBora degradation, it 
would be premature to exclude that other ligases may contribute to hBora degradation, 
particularly during later stages of mitosis or the subsequent G1 phase.  
Through hBora Plk1 acts as an upstream regulator of Aurora A  
Both Plk1 and Aurora A regulate key events during late G2 and early mitosis, 
including centrosome maturation and spindle assembly. Most recently, Plk1 was also 
found to be required for Aurora A localization to centrosomes, suggesting that it might 
act upstream of Aurora A (De Luca et al., 2006; Hanisch et al., 2006). In principle, this 
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latter observation might reflect a direct interaction between the two kinases, or a need 
for Plk1 to phosphorylate a particular substrate that would in turn be required for Aurora 
A recruitment to the centrosome. Although plausible, these two mechanisms presently 
lack experimental support. Our present data, centered on hBora, suggest an alternative 
explanation. Specifically, we propose that Plk1 activity is required to keep hBora levels 
below a certain threshold, such as to prevent sequestration of Aurora A into cytoplasmic 
complexes with hBora. In support of this view, several of the early mitotic defects 
typically seen in cells deprived of Plk1 protein and/or activity could be rescued by hBora 
co-depletion. This implies that the centrosome maturation and separation defects seen 
in Plk1-depleted cells may be attributed, at least in part, to the hBora-mediated 
impairment of Aurora A function. 
We emphasize that not all early mitotic functions of Plk1 can be explained 
through hBora-mediated regulation of Aurora A. In particular, co-depletion of hBora did 
not rescue the chromosome congression defect or the mitotic arrest typically seen in 
Plk1-depleted cells. This notwithstanding, our studies on hBora have uncovered an 
important mechanistic relationship between Plk1 and Aurora A. Thus, it is interesting to 
consider the possible implications of this relationship for the proposed roles of mitotic 
kinases in tumorigenesis. Both Plk1 and Aurora A are often overexpressed in tumors 
(Knecht et al., 1999; Sen et al., 1997) and Aurora A is considered a cancer susceptibility 
gene (Ewart-Toland et al., 2003; Meraldi et al., 2004). It is intriguing, therefore, that 
hBora also maps to a chromosomal region (13q21) that is often altered in tumors 
(Rozenblum et al., 2002). In consideration of the data reported here, one would predict 
that deregulation of hBora should lead to similar cellular phenotypes as the aberrant 
expression of either Plk1 or Aurora A.  
2. Functions of human Aurora A kinase 
The role of Aurora A in centrosome maturation and separation, bipolar spindle assembly 
is mainly established from genetic studies in different organisms. (Giet and Prigent, 
2000; Glover et al., 1995; Hannak et al., 2001). In contrast, results obtained through 
depletion or functional inhibition of Aurora A in somatic mammalian cells are confusing. 
Different consequences including mitotic entry delay (Marumoto et al., 2003), multipolar 
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spindle formation (De Luca et al., 2006), chromosome misalignment (Marumoto et al., 
2003), centrosome separation defects (Hoar et al., 2007) and cytokinesis defects 
(Marumoto et al., 2003) have been described. This is probably due to the fact that 
Aurora A plays multiple roles at different stages during mitosis.  
 Our study suggest a role of Aurora A for centriole cohesion and spindle pole 
integrity, in line with the observations from (De Luca et al., 2006). It has been shown 
that centrioles disengage at the end of mitosis, presumably under the control of 
separase (Tsou and Stearns, 2006). The mother centriole then becomes mobile and 
moves rapidly to the midbody, which is considered to be a crucial event for cytokinesis 
(Piel et al., 2001). Thus, it is possible that Aurora A maintains centriole cohesion during 
mitosis before cytokinesis occurs. Interestingly, by making use of the observation that 
hBora overexpression mislocalizes Aurora A and causes monoastral spindle formation, 
we demonstrated that the co-overexpression of active Aurora A kinase (but not of a 
kinase dead mutant) could restore spindle bipolarity in hBora overexpressing cells. This 
implies that Aurora A kinase activity is required for centrosome separation and bipolar 
spindle formation. Furthermore, we explored the function of Aurora A by introducing a 
fragment of hBora that binds only to Aurora A but not to Plk1. This created an 
environment in which Aurora A activity is still present but the kinase is mislocalized. 
These hBora1-232 overexpressing cells formed multipolar spindle with split centrioles. 
Thus, we conclude that the spindle pole localization of Aurora A is required for 
maintaining centriole cohesion.  




Aurora A kinase has been implicated in regulating mitotic entry, centrosome maturation, 
and spindle assembly, but the molecular mechanisms underlying its regulation and 
mode of action still remain largely unknown. In this study, we investigated the 
interaction between Aurora A and hBora, a protein which was originally identified as an 
Aurora activator in Drosophila. We show that hBora is a cell-cycle regulated protein 
required for proper spindle assembly. While hBora can activate Aurora A in vitro, it also 
interacts with Plk1. The interaction between hBora and Plk1 is promoted by Cdk1 
phosphorylation and is required for degradation of hBora, possibly mediated by the 
SCFβ-TrCP. Most importantly, we demonstrate that Plk1 regulates Aurora A function 
during centrosome maturation and assembly by modulating the protein levels of hBora.  
 After characterizing the interaction between Aurora A and hBora, we also tried to 
investigate the function of Aurora A by siRNA mediated depletion and overexpression 
studies. Aurora A depletion led to multipolar spindle formation due to abnormal centriole 
splitting. Interestingly, overexpression of a fragment of hBora which mislocalizes Aurora 
A but not Plk1 showed the same phenotype. In addition, since only the kinase active 
version of Aurora A could rescue bipolar spindle formation in hBora overexpressing 
cells, we speculate that Aurora A may have dual functions at centrosomes. We suggest 
that the kinase activity of Aurora A is required for centrosome maturation and 
separation, while the localization of Aurora A is required for maintaining centriole 
cohesion. 
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Materials and Methods 
Plasmid constructions and site directed mutagenesis  
Human LATS1 cDNA was a kind gift from Hideyuki Saya and MST1 and MST4 
plasmids were kindly provided by Francis Barr. LATS2 was assembled from three 
expressed sequence tags (ESTs) (ID: IMAGp998K2462472Q2, IMAGp998M236303Q2, 
IMAGp998F098723Q2), hWW45 from EST (ID: IMAGp998J155583), hBora from EST 
(ID: IRAKp961O2411Q2), β-TrCP1 from EST (ID: HU3_p983C04289D). All ESTs were 
obtained from the “Deutsches Ressourzentrum für Genomforschung” (RZPD). Mst2 was 
obtained from a λgt11 cDNA library (Stratagene). All cDNAs were cloned into pRcCMV 
vectors in-frame with sequences that encode amino-terminal FLAG, EGFP or 3x myc 
tags. Site-directed mutagenesis was performed by PCR with oligonucleotides containing 
appropriate mutations. Constructs encoding catalytically inactive kinases were created 
by changing a conserved aspartate in subdomain VII, to an alanine (Lats1D846A, 
Lats2D809A, Mst2D164A). Mutations in hBora phosphodegron and PBD docking site 
were created by changing conserved serine or threonine residues to alanine (S252A, 
S497A/T501A. All constructs were verified by sequencing.  
Cell culture, synchronization, and transfection 
HeLaS3 and HEK293T cells were grown at 37°C in a 5% CO2 atmosphere in 
Dulbecco’s modified Eagle’s medium (Gibco-BRL), supplemented with 10% heat 
inactivated fetal calf serum (FCS) and penicillin-streptomycin (100 IU/ml and 100 mg/ml, 
respectively). Okadaic acid (OA) treatment of cells was performed by adding 1µM OA 
(Alexis) to the culture medium for 1h at 37°C.  
293T cells were arrested at prometaphase stage by 500ng/ml nocodazole for 18h. 
HeLaS3 cells were synchronized at the G1/S phase border by a double aphidicolin or 
thymidine block as follows. Cells were first treated for 12h with 1.6μg/ml aphidicolin 
(Sigma) or 1mM thymidine, then washed 3 times with PBS and released for 12h into 
fresh medium before drug was added again for another 12h. Cells were subsequently 
washed three times in PBS and released into fresh medium after which samples were 
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taken at regular intervals. To arrest HeLaS3 cells at prometaphase, cells were first pre-
synchronized at the G1/S phase border by treatment with 1.6μg/ml aphidicolin for 12h. 
Cells were then washed three times in PBS and released into medium containing 50 
ng/ml nocodazole (Sigma) and culturing was continued for an additional 14h. After that, 
mitotic cells were collected by mechanical shake-off, washed twice with PBS, and 
released into normal growth medium. Samples were taken either from the arrested cells 
or after release at various time intervals. Alternatively, cells were treated with 150 µg/ml 
Monastrol (Sigma) for 16h. 
Transfection of HEK293T cells for purifying recombinant proteins were performed 
using the calcium phosphate method as described by (Seelos, 1997). HeLaS3 cells 
were transfected for immunofluorescence microscopy by using Fugene (Roche), 
according to the manufacturer’s instructions.   
Generation of stable cell lines 
To generate the myc-hBora and myc-hBora(1-327) Tet-on inducible stable cell 
lines, Tet-on HeLaS3 and HEK293 TrexTM cells were transfected in 15 cm dishes with 
5μg plasmids by Fugene. After 48h, transfected cells were selected by 1.5μl/ml 
puromycin for 48h and diluted for single cell colony formation. The stable cell lines were 
then grown at 37°C in a 5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium 
(Gibco-BRL), supplemented with 10% heat inactivated fetal calf serum (FCS) and 
penicillin-streptomycin (100IU/ml and 100mg/ml, respectively) in the presence of 2μg/ml 
blasticidin and 1.5μg/ml puromycin for selection. Expression of myc-hBora and myc-
hBora(1-327) were induced by 1μg/ml tetracycline. 
Cell extracts and Western blot analysis 
Cells were washed with ice cold PBS containing 1mM phenylmethylsulfonyl 
fluoride (PMSF) and resuspended in ice cold HEPES lysis buffer (50 mM Hepes pH7.4, 
150mM NaCl, 0.5% Triton X-100) containing 1μM OA, 30μg/ml RNase A, 30μg/ml 
DNase and protease and phosphatase inhibitors (Sillje et al., 1999). After 15min on ice, 
cells were collected by scraping and centrifuged at 13000 RPM for 15min at 4°C. 
Protein concentrations were determined using the Dc protein assay (Bio-Rad).  
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For immunoblotting, equal amounts of protein were separated by SDS-PAGE 
followed by transfer to nitrocellulose membranes (Schleicher & Schuell). Membranes 
were probed with the following antibodies: affinity-purified rabbit anti-Lats1 (1μg/ml), 
affinity-purified rabbit anti-hBora (1μg/ml), anti-FLAG antibodies (1:1000; rabbit; sigma), 
9E10 anti-myc (1:5), anti-Plk1 (1:5), anti-GFP (1:5), Aurora A antibodies (1:1000; 
mouse; BD Transduction Laboratories), anti-Aurora B (AIM1) (1:500; mouse; BD 
Transduction Laboratories), anti-TPX2 (1:1000; mouse; Abcam, Cambridge, UK), anti α-
tubulin (1:3000; mouse; Sigma-Aldrich), anti-cyclin B1 (1:1000; mouse; Sigma). Primary 
antibodies were detected with HRP-conjugated anti-mouse or anti-rabbit antibodies 
(Pierce). Signals were detected by ECL SuperSignal (Pierce Chemical Co.).     
Spindle preparation 
For mitotic spindle isolations, HeLaS3 cells were firstly arrested in G1/S by the 
addition of 1.6µg/ml aphidicolin for 12h. Upon release from this block, 50ng/ml 
nocodazole was added and cells were grown for another 12h. Mitotic cells were 
obtained by shake-off, washed and released into fresh medium for 1h. At this time point 
the mitotic spindles had reformed and after addition of 5µg/ml taxol or 100ng/ml 
nocodazole (negative control) for 5min. cells were harvested. The subsequent spindle 
isolation procedure was essentially as described before (Sillje and Nigg, 2006). 
Preparation of Baculoviruses, Sf9 cell culture, and purification of 
recombinant proteins 
Baculovirus expressing GST-hBora and His-hBora were produced with 
appropriate pVL1393 constructs, using the BaculoGold transfection kit (BD 
PharMingen). Sf9 cells (Invitrogen) were grown in T.C.100 medium supplemented with 
10% heat-inactivated fetal calf serum and 1% penicillin/streptomycin (Invitrogen) at 
27 °C prior to infection with baculoviruses. 48 h post infection, proteins were purified as 
described previously (Kelm et al., 2002) and subjected to SDS-PAGE or used for kinase 
assays. MBP-tagged proteins were purified from E. coli as described (Baumann et al., 
2007) 
                                                                                                                                    Materials and Methods 
85 
Antibody production 
For Lats1 and hBora antibody production, the specific N-terminal Lats1 fragment 
(aa 267-403) and full length hBora were expressed and purified as His6 tagged fusion 
proteins in Escherichia coli, using the bacterial expression vector pQE30 (Qiagen) and 
pET28(Clontech), respectively. Antibodies against these antigens were raised by 
immunization of rabbits with 250μg antigen for four times (Charles River Laboratories). 
For immuno-purification serum was applied to a Ni2+ resin column containing the 
antigen used for immunization. After washing and elution from the column, antibodies 
were dialyzed against PBS, essentially as described before (Chalamalasetty et al., 
2006).  
Immunofluorescence microscopy 
HeLaS3 cells were grown on HCl-treated coverslips while HEK293T cells were 
grown on fibronectin coated coverslips. For paraformaldehyde fixation, cells were fixed 
for 10 min at RT in a 3% paraformaldehyde/2% sucrose solution before permeablizing 
by ice-cold PBS with 0.5% Triton-X-100. To visualize kinetochores staining, cells were 
fixed and permeabilized by PTEMF solution containing 4% formaldehyde; 0.2% Triton-
X-100; 10mM EGTA and 1mM MgCl in 20mM PIPES, pH6.8 for 15min at room 
temperature. For centrosomal protein labeling, cells were fixed by cold methanol at -
20°C for 5min. Coverslips were then washed with PBS and blocked with 1 % BSA in 
PBS. Incubation of both primary and secondary antibodies was done in PBS containing 
1% BSA, inside a humidified chamber for 1-2h at RT. Primary antibodies used were: 
anti-Lats1 (1μg/ml; rabbit) and the corresponding pre-immune antibodies (1μg/ml), anti-
hBora (1μg/ml; rabbit) and the corresponding pre-immune antibodies (1ug/ml), anti-Plk1 
(1:5), anti-Aurora A (1:1000; mouse; BD Transduction Laboratories), anti-Aurora B 
(AIM1) (1:500; mouse; BD Transduction Laboratories), anti-TPX2 (1:1000; mouse; 
Abcam), anti-γ-tubulin (Sigma), anti-pericentrin (Abcam), FITC-labeled anti-α-tubulin 
(1:500; Sigma) and TRITC or FITC-labeled anti-myc 9E10 (1:1000; Santa Cruz 
Biotechnology), anti-α-tubulin (1:200; Sheep; cytoskeleton); monoclonal anti-γ-tubulin 
(1:3000; Sigma); polyclonal Ch-Tog antibodies (1μg/μl; rabbit; kindly provided by Dr. 
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Xiumin Yan). polyclonal CAP350 antibodies (1μg/μl; goat; kindly provided by Dr. Xiumin 
Yan). Secondary antibodies used were: Alexa488- and Alexa568-conjugated goat α-
mouse IgG (Sigma-Aldrich, 1:1000) and Alexa488- and Alexa568-conjugated goat α-
rabbit IgG (Molecular Probes 1:1000). DNA was strained with 2μg/ml diamidino-2-
phenylindole DAPI (Sigma-Aldrich).  
Immunofluorescence microscopy was performed with a Zeiss Axioplan II 
microscope (Carl Zeiss, Jena, Germany) equipped with a 63x oil immersion objective 
and images were acquired using a Micromax charge couple device (CDD) camera 
(Princeton Instruments, Trenton, NJ). Alternatively, a Deltavision microscope on a Nikon 
Eclipse TE200 base (Applied Precision, Issaquah, WA) equipped with an Apo 60_/1.4 
oil immersion objective and a CoolSnap HQ camera (Photometrics) was used for 
collecting 0.15-μm distanced optical sections in the z-axis. Images at single focal planes 
were processed with a deconvolution algorithm depending on the objective used. 
Settings were conservative, with noise filtering set to low and 2 deconvolution cycles. 
The number of z-stacks collected was variable (between 5 and 20), depending on the 
height of the individual cell. Images were projected into one picture using the Softworx 
software (Applied Precision). Exposure times and settings for image processing 
(deconvolution) were constant for all samples to be compared within any given 
experiment. Images were processed with Adobe Photoshop CS (AdobeSystems). 
siRNA transfection 
The following siRNA sequences were used for silencing of different genes and a GL2 
duplex targeting luciferase was used as a control.  
 
Lats1: 5’ AATCCACAAATGCTTCAAGAC 3’ 
hBora1: 5’ CCGGTTGATAATGGCAGTTTA 3’ 
hBora2: 5’ TAACTAGTCCTTCGCCTATTT 3’ 
Plk1: 5’ CGAGCTGCTTAATGACGAGTT 3’ 
Aurora A: 5’ CAGGGCTGCCATATAACCTGA 3’ 
Aurora A2: 5’ 725 ATGCCCTGTCTTACTGTCATT 3’ 
TPX2: 5’ GAA TGG AAC TGG AGG GCT TTT 3’ 
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Annealing of the siRNAs and transfections using oligofectamine (Life Technologies) 
were performed as described (Elbashir et al., 2001). For co-depletion experiments, 
HeLaS3 cells were treated with GL2 or hBora siRNA for 36h. Subsequently fresh media 
was replaced containing combinations of Plk1/GL2 or Plk1/hBora siRNA duplexes for 
another 36h.  
Far Western ligand binding assays 
hBora pre-phosphorylated by Cdk1 in the presence of cold ATP was separated 
by 7.5% SDS-PAGE, Western blotted, then probed with GST-tagged PBD (1μg/ml) for 
2h at 4°C. Bound proteins were then detected by monoclonal anti-Plk1 antibody. 
Immunoprecipitation 
For immunoprecipitation, cell lysates, prepared as described above, or in vitro 
coupled transcription translation (IVT) mixtures, prepared with the TNT-coupled 
reticulocyte lysate system (Promega) were incubated with: immobilized rabbit anti-Lats1 
antibodies, rabbit anti-hBora antibodies, rabbit anti-Aurora A antibodies, rabbit anti-
GFP(kindly provided by Dr. Francis Barr), monoclonal 9E10 anti-myc antibodies or anti-
FLAG®M2 Affinity gel (Sigma). In each case 1μg of antibody was coupled to 1μl 
Sepharose-G or A beads (20μl beads in total) (Pierce). 
To elute FLAG-tagged proteins, the immune complexes were washed twice with 
buffer D (20mM Hepes, pH7.8, 250mM KCl, 0.2mM EDTA and 0.1% NP40) and then 
incubated for 30min at room temperature in the same buffer including 100µg/ml FLAG-
peptide (Sigma).  
In vitro kinase assays 
In vitro kinase assays for immune complexes or recombinant proteins were performed 
in the corresponding kinase buffer. 
Lats1: Hepes kinase buffer (25mM Hepes pH7.4, 50mM NaCl, 5mM MgCl2, 5mM MnCl2, 
5mM β-glycerophosphate and 1mM DTT) 
Plk1 and Cdk1: BRB80 kinase buffer (80 mM Pipes, pH 6.8/0.5 mM, MgCl2/1 mM 
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EGTA, 5mM β-glycerophosphate and 1mM DTT) 
Aurora A: Aurora A kinase buffer (20 mM Hepes, pH 7.4, 150 mM KCl, 5 mM MnCl2, 5 
mM NaF, 1 mM DTT) 
Kinase reactions were carried out at 30°C for 30min in buffer supplemented with 10μM 
ATP and 2μCi [γ-32P] ATP (Amersham Corp.). Reactions were stopped by the addition 
of SDS sample buffer and heating to 95°C. Reaction products were visualized by SDS-
PAGE followed by autoradiography.   
For testing the activation of Aurora A by TPX2 or hBora, Aurora A isolated from bacteria 
were pre-treated with protein phosphatase 1 (PP1) for 30min at 30°C. The reaction was 
then stopped by the addition 0.1μM microcystin.   
PCR on cDNA panels 
The mRNA levels of LATS1 and LATS2 were detected by PCR on cDNA panels 
from Clontech with two pairs of specific oligos. For LATS1, oligos (LATS1-For) 5’-
GAATCCTTAGTTCCTCAGAGGCATGGC-3’ and (LATS1-Rev) 5’-
ACTCTGCATGATTGGTTGTCTGCC-3’ were used and for LATS2, we used oligos 
(LATS2-For) 5’-GGCTCTACGTGCCGCACCCACACCACAAGCAG -3’ and (LATS2-rev) 
5’-GCATGCTCCTCCTTGGCGTCCAAGCCCTCCGCA- 3’. PCR cycles were 35 and 45 
for LATS1 and LATS2, respectively. As to G3DPH, the control oligos from the cDNA 
panels (Clontech) were used for 16 PCR cycles. PCR products were then subjected to 
electrophoresis in agarose gels and visualized by ethidium bromide staining. 
Mass spectrometry 
Coomassie-stained protein bands were in-gel digested by modified trypsin 
(sequencing grade; Promega) (Shevchenko et al., 1996a) and desalted using 
homemade miniaturized reversed-phase columns (Gobom et al., 1999). Matrix-assisted 
laser desorption/ionization time-of-flight (MALDI-TOF) mass spectra were acquired on a 
Reflex III instrument (Bruker Daltonik, Bremen, Germany) in both positive and negative 
reflector modes. 2,5-dihydroxybenzoic acid (Bruker Daltonik) was used as a matrix. 
Mass spectra were searched for peptides showing a difference of 80 mass units, and 
candidate phosphopeptides were submitted to post-source decay fragment ion analysis 
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(Hoffmann et al., 1999b). Peptides showing the typical losses of 98 mass units 
(phosphoric acid) and 80 mass units (phosphate) were accepted as phosphopeptides. 
For peptide sequencing by tandem mass spectrometry, samples were dissolved in 
water/methanol (1/1, v/v) containing 2% formic acid, filled into nanospray needles 
(Protana), and analyzed on a Q-TOF Ultima mass spectrometer (Micromass). 
Yeast two-hybrid studies 
Yeast two-hybrid assays were performed using a system described previously 
(James et al., 1996). Full cDNAs as well as fragments of Lats1 (aa 1-587 or 588-1130), 
Mst2 (aa 1-312, 312-491) and hWW45 (aa 1-194, 194-384) were cloned into pGAD and 
pGBD vectors. S. cerevisiae strain PJ69-4A transformants were selected on YNB 
medium without Leu and Trp and then streaked onto selective YNB plates, lacking Leu, 
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AA    amino acid 
ATP    adenosine 5´-triphosphate 
BSA    bovine serum albumin 
CDK    cyclin-dependent kinase 
CMV    cytomegalo virus 
CO2    carbon dioxide 
DAPI    4´,6-diamidino-2-phenylindole 
DTT    dithiothreitol 
ECL    enhanced chemiluminescence 
EDTA    ethylene dinitrilo tetraacetic acid 
EGTA    ethylene gycol tetraacetic acid 
FCS    fetal calf serum 
HEPES   N-2-Hydroxyethylpiperazine-N`-2-ethane sulfonic acid 
IgG    immunoglobulin G 
IP    immunoprecipitation                                    
IPTG    isopropyl-beta-D-thiogalactopyranoside 
IU    international unit 
KD    catalytically dead 
kDa    kilo-daltons 
LB    luria-broth 
mAb    monoclonal antibody 
MALDI   Matrix assisted laser desorption ionisation 
MT    microtubules 
MS    mass spectrometry 
MW    molecular weight marker 
OA    okadaic acid 
OD    optical density 
PBS    phosphate-buffered saline 
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PCR    polymerase chain reaction 
PIPES   1,4-Piperazinediethanesulfonic acid 
PMSF    phenylmethylsulfonyl fluoride 
Rpm    revolutions per minute 
RT    room temperature 
SDS-PAGE   sodium-dodecylsulfate polyacrylamid gelelectrophoresis 
siRNA    small interference Ribonucleic Acid 
WT    wild-type 
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List of plasmids 
Name Tag Gene Insert Species Vector 
EC   1 Myc syntenin full-length human pcDNA3.1/3xmyc-C 
EC   2   smurf2 full-length Human pBSKS+ 
EC   3 Myc smurf2 full-length Human pcDNA3.1/3xmyc-C 
EC   4 Myc lats1 C-term Human pcDNA3.1/3xmyc-B 
EC   5 Myc lats1KD C-term Human pcDNA3.1/3xmyc-B 
EC   6 Myc lats1 C-term Human pcDNA3.1/3xmyc-A 
EC   7 Myc lats1KD C-term Human pcDNA3.1/3xmyc-A 
EC   8 GST Ndr-substrate 38bp Human pGEX-6P-3 
EC   9 myc-His lats1 full-length Human pcDNA4/TO/myc-HisB 
EC 10 myc-His lats1KD full-length Human pcDNA4/TO/myc-HisB 
EC 11   lats1 S635A human pBSSK+ 
EC 12   lats1 S635E human pBSSK+ 
EC 13   lats1 S635D human pBSSK+ 
EC 14 Myc lats1 S635A human pcDNA3.1/3mycC 
EC 15   lats1 S635E human pcDNA3.1/3mycC 
EC 16   lats1 S635D human pcDNA3.1/3mycC 
EC 17 GST lats1 aa625-639 human pGEX-6P-3 
EC 18 GST lats1 aa680-694 human pGEX-6P-3 
EC 19 GST lats1 aa694-709 human pGEX-6P-3 
EC 20 GST Alg2 Alg2 human pGEX-6P-3 
EC 21 AD Kiaa0008 Kiaa0008 human  pGAD-C1 
EC 22 BD Kiaa0008 Kiaa0008 human  pGBD-C1 
EC 23 AD Kiaa0008 aa 442-920 human  pGAD-C2 
EC 24 BD Kiaa0008 aa 442-920 human pGBD-C2 
EC 25 AD Kiaa0008 aa 1-441 human pGAD-C1 
EC 26 BD Kiaa0008 aa 1-441 human pGBD-C1 
EC 27   Omi Omi human  pCR4-TOPO 
EC 28   Omi aa133-459 human  pCR4-TOPO 
EC 29 Myc-His Omi Omi human  pcDNA/TO/myc-HisA 
EC 30 His Omi aa133-459 human pET-28a(+) 
EC 31 Flag Mst2 Mst2 human pcDNA3.1+ N-Flag 
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EC 32 Flag - - - pcDNA3.1+ N-Flag 
EC 33 Myc lats1 T1079A human pcDNA3.1/3mycC 
EC 34   Omi Omi human pOTB7 
EC 35   FAM FAM human pT7T3D-PacI 
EC 36   FAM FAM human pT7T3D-PacI 
EC 37   Smurf2 Smurf2 human pT7T3D-PacI 
EC 38   Smurf2 Smurf2 human pT7T3D-PacI 
EC 39 Flag Smurf2 Smurf2 human ? 
EC 40 Flag Mst2 Mst2 human pcDNA3.1+ N-Flag 
EC 41 AD Mst2 full-length human pGAD-C2 
EC 42 BD Mst2 full-length human pGBD-C2 
EC 43 BD hWW45 aa190-384 human pGBD-C1 
EC 44 BD hWW45 aa1-190 human  pGBD-C1 
EC 45 Myc Lats1 S909A human  pcDNA3.1 Myc-C 
EC 46 Myc Mst1 full-length human  pcDNA3.1 Myc-A 
EC 47   Mst2 full-length human  pCR4-TOPO 
EC 48   Mst2 aa1-311 human  pCR4-TOPO 
EC 49   Mst2 aa312-488 human  pCR4-TOPO 
EC 50 BD Mst2 aa1-311 human  pGBD-C1 
EC 51 BD Mst2 aa312-488 human  pGBD-C1 
EC 52   DJ1042 EST of DJ1042 human pOTB7 
EC 53 Myc lats1 full length S872A human  pcDNA3.1MycC 
EC 54 Myc lats1 full length S872E human  pcDNA3.1MycC 
EC 55 Myc lats1 full length S872D human  pcDNA3.1MycC 
EC 56   Mst1 full length human  pCR4-TOPO 
EC 57 Myc Mst1 D167A human pcDNA3.1MycA 
EC 58 Myc lats1 S909A/T1079A human pcDNA3.1MycC 
EC 59 AD Mst2 aa1-311 human pGAD-C1 
EC 60 AD Mst2 aa312-488 human pGAD-C1 
EC 61 Myc DJ1042 full length human pcDNA3.1MycC 
EC 62 GST Lats1 aa626-644 human pGEX-6P-3 
EC 63 GST Lats1 aa1066-1085 human pGEX-6P-3 
EC 64 Flag Mst1 D167A human pcDNA3.1Flag 
EC 65 Flag Mst1 full length human pcDNA3.1Flag 
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EC 66 Myc Lats1  T1036A/S1037A human pcDNA3.1MycC 
EC 67 GST Lats1 aa590-640 human pGEX-5X-2 
EC 68 GST Lats1 aa590-755 human pGEX-5X-2 
EC 69 Myc Lats1 S690A human pcDNA3.1MycC 
EC 70 Myc Lats1 S818A human pcDNA3.1MycC 
EC 71 Myc Lats1 S909D human pcDNA3.1MycC 
EC 72 Myc Lats1 S909E human pcDNA3.1MycC 
EC 73 Myc Lats1 T1079D human pcDNA3.1MycC 
EC 74 Myc Lats1 T1079E human pcDNA3.1MycC 
EC 75 Myc Lats1 S690D human pcDNA3.1MycC 
EC 76 Myc Lats1 S690E human pcDNA3.1MycC 
EC 77 Myc Lats1  T967A human pcDNA3.1MycC 
EC 78 Myc Lats1 T967D human pcDNA3.1MycC 
EC 79 Myc Lats1 T967E human pcDNA3.1MycC 
EC 80 Flag Lats1 aa663-1130 human pcDNA3.1FlagC 
EC 81 Flag Lats1 aa663-1130 KD human pcDNA3.1FlagC 
EC 82 Flag Lats1 aa558-1130 human pcDNA3.1FlagA 
EC 83 Flag Lats1 aa558-1130 KD human pcDNA3.1FlagA 
EC 84 Myc Lats1 T1060A human pcDNA3.1MycC 
EC 85 Myc Lats1 T1060D human pcDNA3.1MycC 
EC 86 Myc Lats1 T1060E human pcDNA3.1MycC 
EC 87 Myc Ysk1 full length human pcDNA3.1/3xmyc-A 
EC 88 Myc Mst4 full length human pcDNA3.1/3xmyc-A 
EC 89 Myc Ysk1 D158A human pcDNA3.1/3xmyc-A 
EC 90 myc Mst4 D162A human pcDNA3.1/3xmyc-A 
EC 91 flag Ysk1 full length human  pcDNA3.1/3xFLAG-A 
EC 92 flag Mst4 full length human pcDNA3.1/3xFLAG-A 
EC 93 flag Ysk1 D158A human pcDNA3.1/3xFLAG-A 
EC 94 flag Mst4 D162A human pcDNA3.1/3xFLAG-A 
EC 95 myc Lats1 aa588-1130, S909T human pcDNA3.1/3xmyc-C 
EC 96 myc Lats1 aa588-1130, T1079A human pcDNA3.1/3xmyc-A 
EC 97 myc Lats1 aa588-1130, T1079D human pcDNA3.1/3xmyc-A 
EC 98 myc Lats1 aa588-1130, T1079E human pcDNA3.1/3xmyc-A 
EC 99 myc Lats1 T1012A human pcDNA3.1/3xmyc-C 
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EC100 myc Lats1 T1031A human pcDNA3.1/3xmyc-C 




EC102 flag hWW45 full length human pcDNA3.1/3xFLAG-C 
EC103 myc Lats1 S909E, T1079E human pcDNA3.1/3xmyc-C 
EC104   D19SH3 EST full length human  pDNR-LIB 
EC105   D19SH3 EST full length human pcmv-SPORT 6 
EC106 myc D19SH3 full length human pcDNA3.1/3xmyc-C 
EC107 flag Rassf1A full length human  pCMV-Tag1 
EC108 myc AuroraA full length human pcDNA3.1/3xmyc-C 
EC109 myc AuroraA D274A human pcDNA3.1/3xmyc-C 
EC110 myc Rassf1A full length human pcDNA3.1/3xmyc-A 
EC111 Flag AuroraA WT human pcDNA3.1/Flag-A 
EC112 Flag AuroraA D274A human pcDNA3.1/Flag-A 
EC113 HA Rassf1A full length human pcDNA3.1/3xmyc-A 
EC114 AD Rassf1A full length human pGAD-C2 
EC115 BD Rassf1A full length human  pGBD-C2 
EC116 HA Lats1 full length human pcDNA3.1/HA-C 
EC117 Flag hWW45 full length human pcDNA3.1/Flag-C 
EC118 Flag Rassf1A full length human pcDNA3.1/FlagA 
EC119 HA Mst2 full length human pcDNA3.1/HA-C 
EC120 GST hWW45 a.a.197-221 human pGEX-6P-3 
EC121 GST hWW45 full length human pGEX-6P-3 
EC122   CMT2 EST full length human   
EC123 Myc CMT2 full length human pcDNA3.1/Myc-C 
EC124   DDX3 EST full length human   
EC125 Myc DDX3 full length human pcDNA3.1/Myc-C 
EC126 His Rassf1A full length human pQE-32 
EC127 His Rassf1A a.a.1-105 human pQE-32 
EC128 Myc Mst2 full length human pcDNA3.1/Myc-C 
EC129   Mst1 full length human pBSSK 
EC130   Mst2 full length human pBSKS 
EC131   Rassf1A full length human pBSKS 
EC132 FLAG Rassf1A full length human pcDNA4/TO Puromycin 
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EC133 His Rassf1A full length human pET28c 
EC134 Myc Mst2 full length human pcDNA4/TO Puromycin 
EC135 FLAG Mst1 full length human pcDNA3.1-C-FLAG 
EC136 FLAG Mst2 full length human pcDNA3.1-C-FLAG 
EC137 FLAG Lats1 full length human pcDNA3.1-C-FLAG 
EC138 FLAG Rassf1A full length human pcDNA3.1-C-FLAG 
EC139   Kiaa0949 EST C-terminal human   
EC140   CRIK EST N-terminal human   
EC141 FLAG CRIK full length Mouse   
EC142 FLAG CRIK KD Mouse   
EC143 FLAG CRIK-SK short form Mouse   
EC144 FLAG CRIK-SK KD short form Mouse   
EC145   hBora EST full length human   
EC146 Myc hBora full length human pcDNA3.1/Myc-C 
EC147 FLAG hBora full length human pcDNA3.1/Flag-C 
EC148 AD hBora full length human pGAD-C(1) 
EC149 BD hBora full length human pGBD-omega-C(1) 
EC150 N-termHis hBora full length human pET-28b-HS2 
EC151 C-term His hBora full length human pET-28b-HS1 
EC152 Myc hBora a.a.1-267 human pcDNA3.1/Myc-C 
EC153 Myc hBora aa268-559 human pcDNA3.1-Myc 
EC154 C-term Myc hBora full-length human pcDNA4/TO/myc-His A 
EC155 BD hBora aa1-267 human pGBD-omega-C(2) 
EC156 BD hBora aa268-559 human pGBD-omega-C(2) 
EC157 AD hBora aa1-267 human pGAD-C(2) 
EC158 AD hBora aa268-559 human pGAD-C(2) 
EC159 Myc hBora full-length human pcDNA4/TO Puro 
EC160 MBP hBora full-length human pMALpFN 
EC161  Kiaa0097 EST human  
EC162 Myc hBora aa1-327 human pcDNA3.1-Myc 
EC163 Myc hBora aa329-559 human pcDNA3.1-Myc 
EC164 Myc RanBP1 full-length human pcDNA3.1-Myc 
EC165 GFP hBora full-length human pEGFP T7/C1 
EC166 Myc beta-TrCP full-length mouse  
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EC167 GST hBora full-length human pVL13GST92 
EC168 His hBora full-length human 
pVL1393N-
termPreScission 
EC169 Myc hBora aa1-329 human pcDNA4/TO Puro 
EC170 Myc hBora aa1-80 human pcDNA3.1-Myc 
EC171 Myc hBora aa80-327 human pcDNA3.1-Myc 
EC172 Myc hBora T52A human pcDNA3.1-Myc 
EC173 Myc hBora R193A/L196A human pcDNA3.1-Myc 
EC174 Myc hBora T15A human pcDNA3.1-Myc 
EC175 Myc hBora S252 human pcDNA3.1-Myc 
EC176 Myc hBora S188A human pcDNA3.1-Myc 
EC177 Myc hBora S262A human pcDNA3.1-Myc 
EC178 Myc hBora S298A human pcDNA3.1-Myc 
EC179 Myc hBora T144A human pcDNA3.1-Myc 
EC180 Myc hBora S497A/T501A human pcDNA3.1-Myc 
EC181 Myc hBora S274A/S558A human pcDNA3.1-Myc 
EC182 Myc hBora T296A human pcDNA3.1-Myc 
EC183 Myc hBora T296A, T144A human pcDNA3.1-Myc 
EC184 Myc hBora T296A, S262A human pcDNA3.1-Myc 
EC185 Myc hBora S274A human pcDNA3.1-Myc 
EC186 Myc hBora S558A human pcDNA3.1-Myc 
EC187 Myc hBora S252A, S274A human pcDNA3.1-Myc 
EC188 Myc hBora S252A, S558A human pcDNA3.1-Myc 
EC189 Myc hBora S325A human pcDNA3.1-Myc 
EC190 MBP hBora S252A human pMALpFN 
EC191 MBP hBora S497A/T501A human pMALpFN 
EC192 GFP beta-TrCP full-length mouse pEGFP T7/C1 
EC193 Myc hBora aa1-327, S252A human pcDNA3.1-Myc 
EC194 Myc hBora aa329-559, S497A/T501A human pcDNA3.1-Myc 
EC195 Myc hBora aa1-232 human pcDNA3.1-Myc 
EC196 MBP hBora aa1-327 human pMALpFN 
EC197 MBP hBora aa329-559 human pMALpFN 
EC198 MBP hBora aa329-559, S497A/T501A human pMALpFN 
EC199 Myc hBora S252E human pcDNA3.1-Myc 
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EC200 Myc hBora S497E/T501E human pcDNA3.1-Myc 
EC201 Myc hBora S251A/S252A human pcDNA3.1-Myc 
EC202 myc hBora S251A human pcDNA3.1-Myc 
EC203 FLAG beta-TrCP full-length human pcDNA3.1-Flag-C 
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